Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3003245	s-c1inh	g/l (g/l)	1234	1482	0.07%
3003245	s-c1inh	— (—)	389	467	100.00%	Distribution not available
3003245	p-c1inh	g/l (g/l)	148	164	0.00%
3003245	s-c1inh	g/l_______ (g/l)	33	35	0.00%
3003245	p-c1inh	— (—)	30	35	100.00%	Distribution not available
3003245	p-c1inh	g/L (g/l)	11	11	0.00%	Distribution not available
3003245	p-c1inh	G/L (g/l)	11	11	0.00%
3003245	p-c1-esteraasininhibiittori	g/l (g/l)	7	7	0.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Urticaria

625

416

15.60

307.65

1.3

1.2

0.30

g/l

0.13

502

332

Urticaria and erythema

648

506

13.20

307.65

1.3

1.2

0.30

g/l

0.15

518

409

Other and unspecified effects of external causes

773

364

22.37

307.65

1.3

1.2

0.31

0.29

g/l

2.17

603

298

Adverse effects, not elsewhere classified

749

255

31.72

307.65

1.3

1.2

0.31

0.29

g/l

1.90

584

209

Other and unspecified urticaria

452

259

18.25

307.65

1.3

1.2

0.30

g/l

0.15

352

208

Oedema, not elsewhere classified

479

317

15.12

307.65

1.4

1.2

0.30

g/l

0.01

389

253

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

176

124

14.79

195.30

1.3

1.2

0.32

0.29

g/l

1.93

134

106

Other and unspecified drugs and medicaments

165

114

15.10

185.12

1.3

1.2

0.32

0.30

g/l

1.38

125

Oral corticosteroids

644

963

3.95

183.85

1.3

1.2

0.31

0.30

g/l

4.10

520

757

ILD medications: prednisolone, methylprednisolone, prednisone

636

912

3.90

175.15

1.3

1.2

0.31

0.30

g/l

2.31

524

704

Inflammatory bowel disease treatment related agents

628

1009

3.47

147.85

1.3

1.2

0.31

0.30

g/l

2.98

510

792

ILD medications

615

945

3.53

146.44

1.3

1.2

0.31

0.30

g/l

1.93

506

730

First line medication for Crohn's disease

603

914

3.57

145.87

1.3

1.2

0.31

0.30

g/l

1.29

492

712

General symptoms and signs

547

712

3.87

143.02

1.3

1.2

0.30

g/l

0.14

442

563

Diseases of the skin and subcutaneous tissue

456

551

4.17

130.94

1.2

0.30

g/l

0.03

369

432

Headache

373

688

4.21

128.70

1.3

1.2

0.30

g/l

0.34

294

545

Dermatographic urticaria

116

14.15

125.80

1.2

0.30

0.29

g/l

0.36

Exposure to unspecified factor

546

1248

2.99

109.49

1.3

1.2

0.31

0.30

g/l

0.80

416

1013

Dermatitis and eczema

558

1173

2.83

97.48

1.2

0.30

g/l

0.14

470

914

Pain in joint

302

477

3.91

87.32

1.3

1.2

0.30

g/l

0.22

242

376

Allergic urticaria

10.03

83.89

1.1

1.2

0.31

0.29

g/l

1.01

Asthma (only as main-diagnosis), excluding more controls

355

585

3.37

80.49

1.2

0.31

0.30

g/l

2.70

289

466

Immunodeficiencies

12.21

80.25

2.2

1.2

0.26

0.29

g/l

1.20

Asthma (only as main-diagnosis)

359

606

3.33

80.17

1.2

0.31

0.30

g/l

2.33

293

485

Other soft tissue disorders, not elsewhere classified

464

940

2.82

79.74

1.2

0.31

0.30

g/l

2.25

377

752

Dermatitis

321

1000

3.16

78.10

1.2

0.31

0.30

g/l

0.89

264

786

Other and unspecified dermatitis

280

835

3.37

76.37

1.2

0.31

0.30

g/l

0.63

233

658

Examination and observation for other reasons

268

384

3.96

76.18

1.2

0.31

g/l

0.19

236

291

Asthma (mode)

368

612

3.17

74.79

1.2

0.31

0.30

g/l

2.11

295

490

Asthma, excluding more controls

360

585

3.17

72.58

1.2

0.31

0.30

g/l

2.30

290

466

Pain, not elsewhere classified

158

322

4.95

72.51

1.3

1.1

0.31

0.29

g/l

0.93

127

257

Allergic rhinitis

187

431

4.32

72.31

1.2

0.30

0.29

g/l

0.49

147

358

Asthma

365

606

3.12

71.82

1.2

0.31

0.30

g/l

2.27

295

485

Malaise and fatigue

232

482

3.81

70.82

1.3

1.1

0.32

0.30

g/l

2.09

178

386

Migraine

311

784

3.11

69.39

1.2

0.30

g/l

0.06

251

622

Abnormalities of breathing

413

879

2.70

65.82

1.3

1.2

0.31

0.30

g/l

1.86

316

699

Biological medicines for asthma

17.35

64.67

1.4

1.2

0.31

0.29

g/l

0.65

Pain in throat and chest

394

861

2.72

64.43

1.3

1.2

0.31

0.30

g/l

0.73

324

689

Unspecified privation

101

154

6.68

63.22

1.3

1.2

0.31

0.29

g/l

1.44

121

Sequelae of other external causes

9.74

62.35

1.5

1.2

0.30

0.29

g/l

0.46

Complications of medical and surgical care

351

1191

2.66

61.53

1.3

1.2

0.31

0.30

g/l

1.28

267

968

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

10.74

60.92

1.2

0.31

0.29

g/l

0.75

Pain in limb

384

927

2.64

60.82

1.3

1.2

0.31

0.30

g/l

3.14

312

743

Fever of other and unknown origin

228

602

3.29

57.92

1.3

1.2

0.31

0.30

g/l

1.12

185

480

Other specific joint derangements/joint disorders

359

853

2.63

56.22

1.3

1.2

0.30

g/l

0.32

291

677

Asthma (diagnoses ohter than nonallergic)

403

1357

2.41

56.16

1.2

0.31

0.30

g/l

1.74

319

1083

242

801

3.02

54.81

1.2

0.30

g/l

0.78

194

646

Asthma, hospital admissions , main diagnosis only

379

1368

2.42

54.27

1.2

0.31

0.30

g/l

1.51

307

1087

Asthma-related infections

284

1011

2.75

54.23

1.2

1.3

0.31

0.30

g/l

0.69

231

813

Asthma, hospital admission 2, infections

284

1011

2.75

54.23

1.2

1.3

0.31

0.30

g/l

0.69

231

813

Asthma and allergy

153

6.13

54.16

1.1

0.31

0.29

g/l

1.36

129

Dorsalgia

424

937

2.41

52.78

1.3

1.2

0.30

g/l

0.10

341

741

Vasomotor and allergic rhinitis

209

653

3.15

50.80

1.2

0.30

g/l

0.01

168

525

Asthma, unspecified (mode), excluding more controls

235

554

3.05

49.90

1.2

0.31

0.30

g/l

1.22

178

443

Tramadol

341

810

2.54

49.36

1.3

1.2

0.32

0.30

g/l

4.58

278

653

Other special examinations and investigations of persons without complaint or reported diagnosis

241

385

3.18

48.84

1.3

1.2

0.29

0.31

g/l

1.62

191

292

Asthma, unspecified (mode)

237

575

2.99

48.77

1.2

0.31

0.30

g/l

1.14

180

462

Symptoms and signs involving the skin and subcutaneous tissue

331

1293

2.43

48.65

1.3

1.2

0.31

0.30

g/l

0.29

265

1031

Disturbances of skin sensation

170

498

3.44

48.00

1.3

0.30

g/l

0.24

130

398

Low back pain

334

917

2.47

47.08

1.3

1.2

0.30

g/l

0.06

270

723

Acute upper respiratory infections of multiple and unspecified sites

344

1048

2.40

46.75

1.3

1.2

0.30

g/l

0.02

277

823

Other/unspecified dorsalgia

184

569

3.21

46.48

1.3

1.2

0.31

0.30

g/l

0.13

147

457

Certain disorders involving the immune mechanism

122

291

4.24

46.29

1.9

1.2

0.28

0.30

g/l

1.12

242

Opioids

407

915

2.30

45.92

1.2

0.31

0.30

g/l

1.62

317

734

Asthma, including avohilmo

482

1253

2.12

45.74

1.2

0.31

0.30

g/l

1.32

387

1004

Sequelae of external causes of morbidity and mortality

140

373

3.78

45.58

1.3

1.2

0.32

0.30

g/l

1.98

114

297

General examination and investigation of persons without complaint and reported diagnosis

229

385

3.10

45.02

1.2

0.30

0.31

g/l

0.22

189

292

Other dorsopathies, not elsewhere classified

410

948

2.25

44.08

1.3

1.2

0.30

g/l

0.73

335

748

Atopic dermatitis

286

910

2.51

43.70

1.3

1.2

0.30

g/l

0.07

240

707

Migraine with aura

163

494

3.32

43.62

1.2

0.30

g/l

0.02

133

402

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

226

794

2.76

43.36

1.4

1.2

0.30

0.31

g/l

0.06

169

636

Other headache syndromes

209

732

2.86

43.29

1.2

1.3

0.30

g/l

0.31

171

598

Irritable bowel syndrome

160

482

3.34

43.27

1.3

1.2

0.30

g/l

0.05

125

386

Symptoms and signs involving the circulatory and respiratory systems

399

883

2.27

43.23

1.3

1.2

0.30

g/l

0.20

322

702

Medical observation and evaluation for suspected diseases and conditions

228

385

3.04

43.18

1.3

1.2

0.30

0.31

g/l

0.38

201

292

Dyspnoea

375

1215

2.23

43.17

1.3

1.2

0.31

0.30

g/l

1.74

292

985

Acute upper respiratory infections

414

1153

2.16

41.86

1.3

1.2

0.30

g/l

0.27

341

909

Allergic asthma (mode), excluding more controls

130

341

3.74

41.52

1.2

0.31

0.29

g/l

2.12

107

278

Allergic asthma (mode)

130

345

3.70

40.84

1.2

0.31

0.29

g/l

1.87

107

281

Myalgia

138

394

3.53

40.62

1.3

1.2

0.31

0.29

g/l

1.49

108

316

Anxiety disorders

387

1234

2.16

40.50

1.3

1.2

0.31

0.30

g/l

0.60

311

982

Lower back pain or/and sciatica

437

1315

2.07

40.23

1.3

1.2

0.30

g/l

0.02

353

1043

Neurotic, stress-related and somatoform disorders

383

1228

2.15

39.99

1.3

1.2

0.31

0.30

g/l

0.53

307

978

Codeine

371

898

2.24

39.87

1.2

0.31

0.30

g/l

2.17

294

720

Migraine with aura and triptan purchases

125

339

3.73

39.79

1.2

0.30

0.29

g/l

0.75

103

272

Abnormalities of heart beat

164

511

3.13

39.58

1.3

1.2

0.30

g/l

0.00

135

411

Asthma and allergy, excluding more controls

204

4.59

39.47

1.1

0.31

0.29

g/l

1.68

163

Chronic lower respiratory diseases

478

1253

2.01

39.17

1.2

0.31

0.30

g/l

1.42

374

1003

Diarrhoea and gastroenteritis of presumed infectious origin

307

1209

2.27

38.69

1.3

1.2

0.30

g/l

0.05

255

970

Pollen allergy

133

379

3.49

38.33

1.3

1.2

0.29

g/l

0.07

102

309

Other complications of surgical and medical care, not elsewhere classified

138

5.44

37.82

1.3

1.2

0.31

0.29

g/l

0.75

116

Other joint disorders

366

867

2.21

37.71

1.3

1.2

0.30

g/l

0.25

296

689

Sciatica+with lumbago

222

760

2.60

37.29

1.2

0.31

0.30

g/l

0.10

179

603

Diseases of oesophagus, stomach and duodenum

419

1210

2.05

37.12

1.3

1.2

0.30

g/l

0.08

335

962

Intestinal infectious diseases

385

1389

2.07

36.79

1.3

1.2

0.30

g/l

0.29

304

1108

Fibromyalgia

144

5.21

36.09

1.4

1.2

0.31

0.29

g/l

1.92

111

Bronchitis

430

1291

2.00

35.96

1.3

1.2

0.30

g/l

0.24

346

1025

Other diseases of intestines

427

1180

2.02

35.92

1.3

1.2

0.30

g/l

0.70

339

940

Anxiety disorders, excluding more controls

349

1040

2.15

35.68

1.3

1.2

0.31

0.30

g/l

0.67

281

833

ILD medications: immunosuppressive drugs

231

849

2.47

35.27

1.2

0.32

0.30

g/l

3.23

192

657

All anxiety disorders

298

1036

2.24

35.22

1.3

1.2

0.30

g/l

0.60

244

821

Exposure to other specified factors

342

1404

2.10

35.04

1.2

0.31

0.30

g/l

0.67

283

1109

Migraine without aura

133

411

3.26

34.64

1.2

0.30

0.29

g/l

0.30

108

338

Symptoms and signs involving the nervous and musculoskeletal systems

243

1028

2.37

34.58

1.3

0.31

0.30

g/l

0.92

190

834

Soft tissue disorders

387

954

2.08

34.47

1.2

0.31

0.30

g/l

1.73

317

763

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

397

1266

2.02

34.40

1.3

1.2

0.30

g/l

0.72

331

1007

Anxiety (asthma-related co-morbidities)

288

976

2.25

34.30

1.3

1.2

0.30

g/l

0.71

236

775

Other intervertebral disc disorders

313

840

2.23

34.28

1.2

0.30

g/l

0.30

255

662

422

1066

2.01

34.21

1.3

1.2

0.30

g/l

0.09

346

838

Atopic dermatitis, strict definition with reimbursement

158

524

2.91

33.68

1.2

0.30

g/l

0.21

130

415

Dorsopathies

387

951

2.07

33.66

1.3

1.2

0.30

g/l

1.04

318

751

Abdominal and pelvic pain

348

813

2.15

33.56

1.3

1.2

0.29

0.31

g/l

2.39

282

647

GASTRO-related operations

299

655

2.30

33.41

1.3

1.2

0.30

g/l

0.13

232

536

Any gastric operation

299

655

2.30

33.41

1.3

1.2

0.30

g/l

0.13

232

536

Syncope and collapse

145

394

3.08

33.03

1.2

1.1

0.31

0.30

g/l

0.92

119

315

Codeine or tramadol medication

429

1195

1.95

32.77

1.2

0.31

0.30

g/l

1.71

332

964

Other functional intestinal disorders

192

676

2.59

32.37

1.3

1.2

0.31

0.30

g/l

1.20

147

556

Other anxiety disorders

238

863

2.36

32.31

1.2

0.31

0.30

g/l

1.29

193

689

Arthropathies

359

869

2.09

32.31

1.2

0.30

g/l

0.46

285

691

Obesity related asthma

158

568

2.80

31.58

1.2

1.3

0.33

0.30

g/l

4.22

122

462

Other diseases of upper respiratory tract

378

975

2.02

31.48

1.3

1.2

0.30

g/l

0.55

308

774

Gastro-oesophageal reflux disease

267

1020

2.21

31.36

1.3

1.2

0.30

0.31

g/l

0.66

223

815

Persons encountering health services in other circumstances, wide

415

1095

1.95

31.20

1.2

0.31

0.30

g/l

0.48

344

857

Other symptoms and signs involving the nervous and musculoskeletal systems

185

731

2.54

30.65

1.3

1.2

0.31

0.30

g/l

0.45

143

596

Other external causes of accidental injury

285

635

2.25

30.62

1.3

1.2

0.30

g/l

0.14

222

515

Nerve, nerve root and plexus disorders

396

1232

1.93

30.20

1.3

1.2

0.30

g/l

0.09

319

979

Injury, poisoning and certain other consequences of external causes

180

321

2.82

30.13

1.3

1.1

0.29

0.30

g/l

0.49

143

254

Cardiovascular diseases

273

642

2.26

30.12

1.2

0.30

0.29

g/l

0.73

223

503

Dizziness and giddiness

293

1086

2.10

29.80

1.3

1.2

0.31

0.30

g/l

0.86

227

871

Somatoform disorder

267

3.63

29.55

1.4

1.2

0.31

0.29

g/l

1.04

219

Infections of the skin and subcutaneous tissue

245

1097

2.20

29.37

1.3

1.2

0.31

0.30

g/l

1.28

206

884

Other general symptoms and signs

7.14

29.33

1.1

0.30

0.29

g/l

0.35

Persons encountering health services for other counselling and medical advice, not elsewhere classified

395

1094

1.92

28.72

1.2

0.31

0.30

g/l

1.11

339

856

Accidents

279

635

2.21

28.58

1.3

1.2

0.30

g/l

0.09

220

515

Systemic connective tissue disorders

150

554

2.72

28.53

1.2

0.33

0.30

g/l

2.79

124

443

Supplementary factors related to causes of morbidity and mortality classified elsewhere

146

532

2.76

28.51

1.4

1.2

0.30

g/l

0.03

105

432

Symptoms and signs involving the digestive system and abdomen

332

813

2.05

28.39

1.3

1.2

0.29

0.31

g/l

2.06

267

647

Episodal and paroxysmal disorders

391

1032

1.93

28.25

1.2

1.3

0.30

g/l

0.12

318

823

Other systemic involvement of connective tissue (FG)

113

351

3.18

28.24

1.3

1.2

0.32

0.30

g/l

1.48

288

Other noninfective gastroenteritis and colitis

120

395

3.05

28.15

1.2

0.32

0.30

g/l

1.81

319

Intestinal infectious diseases, including avohilmo, including avohilmo

416

1243

1.87

28.11

1.3

1.2

0.30

0.31

g/l

0.66

341

985

Noninfective enteritis and colitis

198

846

2.35

27.63

1.3

1.2

0.31

0.30

g/l

0.71

158

683

Implicit viral Sepsis, including avohilmo

127

436

2.92

27.57

1.3

1.2

0.32

0.30

g/l

1.24

103

352

Asthma/COPD (KELA code 203)

359

1252

1.92

27.53

1.2

0.31

0.30

g/l

1.60

288

1003

Nausea and vomiting

110

340

3.17

27.38

1.2

0.32

0.30

g/l

0.77

270

Rheumatism, unspecified

173

4.20

27.22

1.3

1.2

0.30

g/l

0.04

135

Diseases of salivary glands

151

574

2.65

27.17

1.4

1.2

0.31

0.30

g/l

0.31

125

461

Symptoms and signs involving cognition, perception, emotional state and behaviour

364

1291

1.89

26.56

1.3

1.2

0.31

0.30

g/l

1.22

289

1032

Mood disorders

384

1323

1.86

26.50

1.3

1.2

0.31

0.30

g/l

1.87

312

1055

Certain infectious and parasitic diseases

350

897

1.96

26.49

1.3

1.2

0.30

g/l

0.95

278

712

Mood [affective] disorders

383

1323

1.86

26.38

1.3

1.2

0.31

0.30

g/l

1.76

311

1055

Depression

366

1306

1.88

26.28

1.3

1.2

0.31

0.30

g/l

1.13

298

1042

Lumbar disc prolapse

235

799

2.18

26.08

1.3

1.2

0.30

g/l

0.06

192

634

Triptan medication for migraine, single purchase ok

312

1073

1.97

26.04

1.2

0.30

g/l

0.18

262

850

Migraine, single triptan purchase ok & required. ICD-code if available is included

312

1073

1.97

26.04

1.2

0.30

g/l

0.18

262

850

Anaemias

102

190

3.46

25.73

1.3

1.2

0.31

0.29

g/l

1.31

155

Finngen Rheumatological endpoints

359

1075

1.90

25.72

1.3

1.2

0.31

0.30

g/l

1.53

276

870

Chronic sinusitis

166

678

2.45

25.65

1.3

1.2

0.31

0.30

g/l

1.09

139

547

Vocal cord dysfunction

163

4.02

25.51

1.4

1.2

0.32

0.29

g/l

2.38

133

Chronic rhinitis, nasopharyngitis and pharyngitis

137

512

2.69

25.51

1.2

0.31

0.30

g/l

0.74

107

412

Recurrent or chronic depression

172

479

2.50

25.44

1.4

1.3

0.30

g/l

0.42

140

391

Functional dyspepsia

122

430

2.85

25.42

1.1

1.2

0.30

0.31

g/l

0.13

342

Autoimmune diseases related-to ILD

320

1402

1.91

25.34

1.3

1.2

0.31

0.30

g/l

2.09

259

1116

Migraine without aura and triptan purchases

107

354

3.05

25.02

1.2

0.30

0.29

g/l

0.55

286

Antihypertensive medication - note that there are other indications

258

632

2.14

24.91

1.2

0.30

0.29

g/l

2.39

213

502

Persons encountering health services in other circumstances

169

699

2.40

24.86

1.3

1.2

0.30

g/l

0.15

127

562

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

360

1313

1.85

24.85

1.4

1.2

0.31

0.30

g/l

0.44

278

1060

Persons encountering health services for examination and investigation

189

385

2.47

24.80

1.2

0.29

0.31

g/l

1.40

152

292

Acute sinusitis

214

894

2.18

24.77

1.2

0.31

0.30

g/l

0.64

173

699

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

117

181

3.25

24.74

1.2

1.1

0.28

0.30

g/l

2.22

140

External causes of morbidity and mortality

207

445

2.34

24.24

1.3

1.2

0.29

0.30

g/l

0.13

161

365

Neurological diseases

303

764

2.00

24.23

1.2

1.3

0.30

g/l

0.04

246

601

Cervical disc disorders

130

488

2.68

24.03

1.3

0.30

0.31

g/l

0.36

108

391

Pain (limb, back, neck, head abdominally)

219

485

2.27

24.01

1.2

0.29

0.30

g/l

0.61

175

385

Mood disorders, excluding more controls

341

1070

1.88

23.82

1.3

1.2

0.31

0.30

g/l

2.22

273

857

Hypothyroidism (congenital or acquired)

111

196

3.18

23.67

1.1

1.2

0.30

0.29

g/l

1.01

158

Visual disturbances

192

869

2.22

23.56

1.2

1.3

0.31

0.30

g/l

0.74

149

712

Cervicalgia

274

3.27

23.47

1.3

1.2

0.30

0.31

g/l

0.13

216

Disorders of conjunctiva

326

1362

1.86

23.45

1.2

0.30

g/l

0.14

271

1074

Conjunctivitis

306

1307

1.89

23.32

1.2

0.30

g/l

0.38

252

1030

Allergic contact dermatitis

194

3.74

23.31

1.2

0.29

0.30

g/l

0.24

150

Hypothyroidism and >3 levothyroxin purchases

109

195

3.15

22.84

1.1

1.2

0.30

0.29

g/l

0.78

157

Hypothyroidism, levothyroxine purchases

109

195

3.15

22.84

1.1

1.2

0.30

0.29

g/l

0.78

157

Type of accident

127

486

2.63

22.65

1.4

1.2

0.30

g/l

0.03

394

Subjective visual disturbances

116

424

2.75

22.64

1.2

0.31

0.30

g/l

0.92

340

Other pulmonary diagnosis

253

611

2.08

22.56

1.2

0.30

g/l

0.26

203

489

Spondylosis

179

613

2.29

22.55

1.2

1.3

0.31

g/l

0.15

140

489

Triptan medication for migraine, min. 3 purchases

262

993

1.98

22.53

1.2

0.30

g/l

0.33

209

792

Complications of surgical and medical care, not elsewhere classified

356

1321

1.80

22.52

1.2

0.31

0.30

g/l

2.04

274

1062

Cardiovascular diseases (excluding rheumatic etc)

271

779

2.00

22.47

1.2

0.31

0.29

g/l

2.16

222

616

Sleep apnoea, including avohilmo

347

1155

1.82

22.23

1.2

1.3

0.31

0.30

g/l

1.35

269

934

Visual disturbances and blindness

197

923

2.14

22.13

1.2

1.3

0.31

0.30

g/l

0.74

153

758

Other specified/unspecified arthritis

107

381

2.82

21.94

1.3

0.30

g/l

0.02

310

Implicit Sepsis

257

962

1.97

21.90

1.3

1.2

0.32

0.30

g/l

2.19

210

778

Other systemic involvement of connective tissue

114

422

2.72

21.73

1.3

1.2

0.32

0.30

g/l

1.53

337

Depression medications

120

207

2.93

21.56

1.3

1.2

0.30

0.29

g/l

0.90

167

Polyarthropathies

233

731

2.05

21.47

1.3

1.2

0.31

0.30

g/l

1.37

185

583

Chronic diseases of tonsils and adenoids

274

894

1.94

21.44

1.2

0.30

g/l

0.41

224

710

Neurological diseases, wide definition

115

194

2.99

21.39

1.3

1.2

0.28

g/l

0.03

148

Persons encountering health services for specific procedures and health care

390

1326

1.74

21.37

1.2

0.31

0.30

g/l

2.21

311

1056

Other arthritis (FG)

124

484

2.57

21.27

1.3

1.2

0.30

g/l

0.10

402

Event of undetermined intent

102

4.77

21.27

1.2

0.33

0.29

g/l

1.74

Autoimmune diseases excluding thyroid diseases

361

1102

1.78

20.96

1.2

0.31

0.30

g/l

2.19

289

881

Sleep apnoea

323

1122

1.82

20.86

1.2

1.3

0.31

0.30

g/l

0.94

248

909

Symptoms and signs involving speech and voice

133

543

2.46

20.77

1.3

1.2

0.31

0.30

g/l

0.18

105

437

Gastrointestinal diseases

209

484

2.17

20.77

1.3

1.2

0.29

0.30

g/l

1.62

167

383

Transport accidents

163

596

2.28

20.76

1.3

1.2

0.30

g/l

0.24

126

487

Care involving use of rehabilitation procedures

234

1070

1.97

20.73

1.2

1.3

0.32

0.30

g/l

1.81

191

861

Diseases of the musculoskeletal system and connective tissue

191

427

2.25

20.65

1.3

1.2

0.29

g/l

0.42

150

345

Dysphagia

286

3.06

20.61

1.4

1.2

0.30

0.31

g/l

0.21

232

Any reimbursement code in KELA

233

566

2.07

20.57

1.3

1.2

0.30

0.29

g/l

1.21

197

453

Excluding asthma or asthma-COPD overlap

246

611

2.02

20.46

1.2

0.30

g/l

0.17

197

489

Diseases of tongue

6.53

20.46

1.2

1.3

0.31

g/l

0.07

Spondylopathies

248

741

1.98

20.46

1.3

1.2

0.31

g/l

0.24

196

589

Follow-up examination after treatment for conditions other than malignant neoplasms

131

341

2.56

20.33

1.2

1.3

0.31

0.30

g/l

0.34

258

Hernia of abdominal wall, postoperative

211

3.40

20.32

1.2

0.30

g/l

0.05

177

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

231

1139

1.95

20.00

1.2

1.3

0.30

g/l

0.16

185

902

Atopic dermatitis, strict definition

151

650

2.28

19.84

1.2

0.30

0.29

g/l

0.24

125

520

ILD differential diagnosis

244

612

2.00

19.79

1.2

0.30

g/l

0.23

194

490

Used for control exclusion in common control thyroid runs

355

1016

1.76

19.77

1.2

0.30

g/l

0.25

287

808

COPD differential diagnosis

244

613

2.00

19.71

1.2

0.30

g/l

0.23

194

490

Other condition

233

3.24

19.59

1.6

1.2

0.29

0.30

g/l

0.15

187

COPD/asthma/ILD related infections

344

972

1.78

19.53

1.3

1.2

0.30

g/l

0.29

281

761

COPD/asthma related infections

344

972

1.78

19.53

1.3

1.2

0.30

g/l

0.29

281

761

Cough

144

581

2.32

19.52

1.3

1.2

0.32

0.30

g/l

1.73

117

466

Allergic conjunctivitis

240

1215

1.91

19.49

1.2

0.30

g/l

0.08

194

963

Parasetamol

248

636

1.98

19.46

1.3

1.2

0.30

0.29

g/l

0.69

190

505

Pain and other conditions associated with female genital organs and menstrual cycle

113

363

2.62

19.29

1.3

1.2

0.29

0.30

g/l

0.55

289

Dislocation, sprain and strain of joints and ligaments at neck level

293

2.96

19.21

1.2

0.30

0.29

g/l

0.68

243

Dermatitis due to substances taken internally

5.93

19.17

1.1

1.2

0.31

0.29

g/l

0.70

Viral Sepsis

275

3.00

18.82

1.4

1.3

0.32

0.30

g/l

1.59

221

Autoimmune diseases excluding thyroid diseases, strict definition

340

1059

1.75

18.76

1.2

1.3

0.31

0.30

g/l

1.93

271

843

Dental caries

314

2.81

18.72

1.3

1.2

0.31

0.30

g/l

0.24

250

Cutaneous abscess, furuncle and carbuncle

110

432

2.56

18.71

1.4

1.2

0.32

0.29

g/l

2.39

345

Undetermined asthma, excluding more controls

153

3.74

18.58

1.2

0.31

0.30

g/l

0.56

121

Concussion

176

646

2.12

18.46

1.2

1.3

0.31

0.30

g/l

0.68

132

508

Pruritus

150

3.76

18.36

1.3

1.2

0.32

0.30

g/l

0.66

120

Caries of dentine

273

2.94

18.32

1.4

1.2

0.31

0.30

g/l

0.18

216

Implicit viral Sepsis

274

2.97

18.32

1.4

1.3

0.32

0.30

g/l

1.58

221

Other nutritional deficiencies

260

1308

1.82

18.17

1.2

0.32

0.30

g/l

3.37

212

1037

Undetermined asthma

156

3.67

18.08

1.2

0.31

0.30

g/l

0.47

124

Hypertensive diseases (excluding secondary)

197

557

2.06

18.07

1.2

0.32

0.29

g/l

4.88

162

442

Non-invasive ventilation

291

2.77

17.91

1.2

0.31

0.29

g/l

0.60

243

Heartburn

122

4.04

17.78

1.1

1.2

0.29

0.31

g/l

0.59

Intracranial trauma

198

665

2.02

17.72

1.2

1.3

0.31

0.30

g/l

0.98

153

524

Rash and other nonspecific skin eruption

132

3.90

17.57

1.1

1.3

0.31

0.30

g/l

0.70

107

Disorders of the thyroid gland

325

1229

1.72

17.56

1.2

0.30

g/l

0.23

264

978

Childhood asthma (age<16), excluding more controls

160

3.34

17.49

1.3

1.1

0.28

0.29

g/l

0.31

128

Diseases of the eye and adnexa

284

786

1.81

17.36

1.2

0.30

g/l

0.01

232

634

Hypertension, essential

257

786

1.85

17.27

1.2

0.32

0.30

g/l

5.93

205

629

Disorders of eyelid, lacrimal system and orbit

298

1257

1.74

17.27

1.2

0.30

g/l

0.37

230

1014

Childhood asthma (age<16)

162

3.30

17.17

1.2

1.1

0.28

0.29

g/l

0.31

130

Other diseases of lip and oral mucosa

159

760

2.10

17.16

1.3

1.2

0.30

g/l

0.22

130

617

Sleep disorders (combined)

360

1122

1.68

17.06

1.2

0.30

g/l

0.15

284

909

Implicit Sepsis, including avohilmo

272

1092

1.78

17.04

1.3

1.2

0.32

0.30

g/l

2.20

224

881

Other arthrosis

162

509

2.14

16.89

1.2

0.31

g/l

0.07

134

410

Post-traumatic stress disorder

174

3.42

16.82

1.4

1.2

0.29

g/l

0.03

139

Injuries to the neck

103

414

2.50

16.75

1.2

1.3

0.30

0.29

g/l

0.28

335

Pain in thoracic spine

210

3.16

16.63

1.2

0.30

g/l

0.14

168

Autoimmune diseases

364

1113

1.66

16.55

1.2

0.30

g/l

0.41

294

888

Codes for special purposes

195

1007

1.92

16.52

1.2

1.3

0.31

0.30

g/l

1.75

160

820

Other reaction to severe stress, and adjustment disorders

158

767

2.07

16.35

1.2

0.30

g/l

0.68

120

618

Cervicocranial syndrome

135

3.73

16.25

1.2

1.3

0.29

0.31

g/l

0.92

109

Dentofacial anomalies [including malocclusion]

274

1233

1.74

16.18

1.3

1.2

0.30

g/l

0.16

217

978

Enlarged lymph nodes

154

3.52

16.17

1.7

1.1

0.30

g/l

0.15

126

Provisional assignment of new diseases of uncertain etiology

194

1008

1.91

16.15

1.2

1.3

0.31

0.30

g/l

1.86

159

821

Other heart diseases, wide

329

1192

1.67

15.96

1.3

1.2

0.31

0.30

g/l

1.54

260

953

Complications of procedures, not elsewhere classified

274

1277

1.73

15.93

1.3

1.2

0.31

0.30

g/l

1.84

213

1027

Benzodiazepine use

339

1390

1.65

15.90

1.3

1.2

0.31

0.30

g/l

2.21

272

1104

Temporomandibular joint disorders, including avohilmo

197

1011

1.89

15.82

1.2

0.30

g/l

0.01

152

805

Acute bronchitis

143

665

2.12

15.74

1.3

1.2

0.31

0.30

g/l

1.00

119

537

Other disorders of fluid, electrolyte and acid-base balance

366

2.50

15.69

1.2

1.3

0.32

0.30

g/l

1.63

295

Voice disturbances

106

446

2.39

15.64

1.3

1.2

0.31

0.30

g/l

0.31

357

Diseases of the respiratory system

193

486

1.99

15.64

1.3

1.2

0.30

g/l

0.31

153

390

Endometriosis of pelvic peritoneum

270

2.74

15.55

1.2

0.30

g/l

0.02

216

Hypertension

257

813

1.79

15.45

1.2

0.33

0.30

g/l

7.11

206

650

Hypertensive diseases

257

814

1.78

15.40

1.2

0.33

0.30

g/l

7.16

206

651

Diseases of the ear and mastoid process

390

1222

1.60

15.34

1.3

1.2

0.30

g/l

0.27

311

982

Other bacterial diseases, including avohilmo

337

1284

1.64

15.31

1.3

1.2

0.32

0.30

g/l

3.60

275

1024

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

302

1217

1.68

15.17

1.3

1.2

0.31

0.30

g/l

2.02

250

975

Inflammatory diseases of female pelvic organs

255

996

1.76

15.13

1.3

1.2

0.30

g/l

0.71

199

795

Other arrhythmias

224

923

1.82

15.11

1.2

0.30

g/l

0.21

178

743

Hypothyroidism, other/unspecified

299

1172

1.68

15.03

1.2

0.30

g/l

0.37

239

933

Non-allergic asthma (mode), excluding more controls

216

2.99

14.97

1.2

0.31

0.30

g/l

0.44

170

Rotator cuff syndrome

185

660

1.93

14.91

1.3

1.2

0.31

0.30

g/l

0.33

147

529

Convulsions, not elsewhere classified

232

2.90

14.84

1.3

1.2

0.28

0.30

g/l

0.94

193

Non-allergic asthma (mode)

218

2.97

14.73

1.2

0.31

0.30

g/l

0.36

173

Diaphragmatic hernia

111

491

2.27

14.62

1.3

1.2

0.32

0.30

g/l

1.82

396

Other symptoms and signs involving the digestive system and abdomen

211

3.00

14.59

1.2

0.31

g/l

0.07

173

Other bacterial diseases

297

1181

1.67

14.58

1.3

1.2

0.32

0.30

g/l

4.02

240

952

Heart failure, not strict

216

797

1.82

14.53

1.3

1.2

0.33

0.30

g/l

5.29

179

650

Other disorders of lacrimal gland

132

628

2.11

14.52

1.3

1.2

0.30

0.31

g/l

0.65

105

515

Condition for Implicit Sepsis (Organ dysfunction codes)

275

1127

1.69

14.40

1.3

1.2

0.31

0.30

g/l

1.93

226

904

Disorders of vestibular function (Vertigo)

151

736

2.00

14.40

1.2

0.31

0.30

g/l

0.57

116

605

Behavioural syndromes associated with physiological disturbances and physical factors

319

1326

1.63

14.40

1.2

0.30

g/l

0.19

261

1060

Other disorders of urethra and urinary system

240

952

1.76

14.36

1.2

0.31

0.30

g/l

0.26

188

762

Cardiac arrhythmias

219

775

1.82

14.34

1.3

1.2

0.31

0.29

g/l

1.73

173

624

Conjunctivitis (acute, non atopic), including avohilmo

324

1201

1.63

14.33

1.2

0.30

g/l

0.18

261

951

Cerebrovascular diseases (FINNGEN)

106

315

2.37

14.25

1.3

1.2

0.32

0.30

g/l

2.56

255

Asthma-related pneumonia

111

495

2.24

14.22

1.3

1.2

0.31

0.30

g/l

0.73

394

Other acute lower respiratory infections

181

921

1.88

14.18

1.3

1.2

0.31

0.30

g/l

0.29

148

736

Other antidepressants

320

993

1.65

14.18

1.3

1.2

0.31

0.30

g/l

0.75

267

789

Asthma, hospital admissions 3, pneumonia

111

496

2.24

14.15

1.3

1.2

0.31

0.30

g/l

0.73

395

Asthma-related pneumonia or sepsis

111

496

2.24

14.15

1.3

1.2

0.31

0.30

g/l

0.73

395

Hypothyroidism, strict autoimmune

240

899

1.75

14.14

1.2

1.3

0.30

g/l

0.21

189

724

Hypothyreosis and Thyroxine purchase for inclusion criteria

309

1238

1.64

14.11

1.2

0.31

0.30

g/l

0.61

248

990

Covid-19 confirmed case

125

590

2.12

13.99

1.2

1.3

0.33

0.30

g/l

3.27

475

Dental pulpitis, including avohilmo

328

1307

1.61

13.94

1.2

0.30

g/l

0.17

259

1048

Shoulder lesions

223

745

1.80

13.94

1.3

1.2

0.31

0.30

g/l

0.39

182

597

Cervicobrachial syndrome

324

2.54

13.90

1.3

1.2

0.29

0.31

g/l

1.16

259

Other heart diseases

168

560

1.95

13.82

1.4

1.2

0.31

0.29

g/l

2.28

137

451

Obesity

235

1289

1.72

13.77

1.2

0.32

0.30

g/l

4.50

192

1024

Acute pharyngitis

238

2.80

13.71

1.4

1.2

0.29

0.30

g/l

0.31

192

230

2.84

13.68

1.3

1.2

0.30

0.29

g/l

0.65

186

Obesity and other hyperalimentation

235

1290

1.72

13.66

1.2

0.32

0.30

g/l

4.50

192

1024

Implicit bacterial Sepsis, including avohilmo

128

506

2.11

13.64

1.3

1.2

0.33

0.30

g/l

2.48

104

409

Bacterial infection, other or unspecified

156

674

1.96

13.60

1.3

1.2

0.33

0.30

g/l

3.79

127

546

Enthesopathies of lower limb, excluding foot

328

2.51

13.56

1.2

0.30

g/l

0.13

262

Disorders of thyroid, IBD co-morbidities

146

3.01

13.55

1.2

0.30

0.28

g/l

0.88

117

Tongue abnormality

4.55

13.53

1.2

0.31

0.29

g/l

0.86

Panic disorder

282

2.64

13.53

1.4

1.2

0.30

0.29

g/l

0.40

230

Arthrosis

209

628

1.83

13.51

1.2

0.30

g/l

0.26

168

496

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

118

554

2.14

13.47

1.3

0.30

g/l

0.08

444

Other noninfective disorders of lymphatic vessels and lymph nodes

5.27

13.46

1.1

1.2

0.30

0.29

g/l

0.39

Other disorders of patella

249

2.74

13.43

1.3

0.30

0.29

g/l

0.40

203

Osteopathies and chondropathies

182

906

1.84

13.36

1.2

0.31

0.30

g/l

0.45

142

746

Injuries to the ankle and foot

264

1364

1.66

13.25

1.2

0.31

0.30

g/l

0.83

214

1080

Certain infectious and parasitic diseases, including avohilmo

217

604

1.80

13.17

1.2

0.30

g/l

0.16

171

479

Disorders of lacrimal system

151

769

1.94

13.14

1.3

1.2

0.30

g/l

0.54

121

628

Atypical facial pain

4.54

13.07

1.4

1.1

0.31

0.29

g/l

0.63

Depression or dysthymia

201

601

1.83

13.07

1.3

0.30

0.31

g/l

0.93

162

488

Special screening examination for infectious and parasitic diseases

231

2.56

13.06

1.2

0.29

0.30

g/l

0.51

174

Sequelae with surgical and medical care as external cause

270

2.64

13.04

1.2

0.34

0.30

g/l

3.63

216

STROKE

167

589

1.91

13.04

1.2

0.31

0.30

g/l

1.18

139

478

Unspecified/other endometriosis

173

3.08

13.03

1.2

0.30

0.29

g/l

0.49

141

Erysipelas, including avohilmo

217

921

1.75

12.98

1.3

1.2

0.32

0.30

g/l

1.73

179

743

Noninfectious colitis NAS

200

2.92

12.82

1.2

0.32

0.30

g/l

1.34

165

Other and unspecified vasculitis limited to skin

10.68

12.79

1.3

1.2

0.32

0.28

g/l

1.15

Oxycodone

111

439

2.17

12.78

1.3

1.2

0.32

0.30

g/l

1.36

367

Bacterial infection, other or unspecified, including avohilmo

170

751

1.86

12.67

1.3

1.2

0.33

0.30

g/l

4.06

138

612

Irregular menses

210

903

1.75

12.67

1.3

1.2

0.30

g/l

0.20

163

718

Other diseases of urinary system

313

1102

1.60

12.59

1.3

1.2

0.30

g/l

0.72

257

878

Symptoms and signs concerning food and fluid intake

3.83

12.55

1.2

1.1

0.31

0.30

g/l

0.30

Injuries to the wrist and hand

336

1433

1.56

12.55

1.2

0.30

g/l

0.58

277

1131

Endometriosis

132

371

2.08

12.47

1.2

0.30

g/l

0.11

101

297

Viral and other specified intestinal infections, including avohilmo

110

498

2.13

12.44

1.3

1.2

0.30

0.29

g/l

0.08

402

Erysipelas

157

718

1.89

12.43

1.3

1.2

0.32

0.30

g/l

1.70

128

581

Other and unspecified tonsillitis

129

531

2.02

12.39

1.4

1.2

0.29

0.30

g/l

0.17

101

421

Non-selective monoamine reuptake inhibitors

114

524

2.09

12.29

1.1

1.2

0.31

0.30

g/l

0.74

428

Other and unspecified rosacea

142

3.27

12.29

1.3

1.2

0.29

g/l

0.22

116

Endocrine, nutritional and metabolic diseases

262

793

1.67

12.29

1.2

0.31

0.29

g/l

2.58

214

625

Sleep disorders

301

1311

1.58

12.20

1.2

0.30

g/l

0.31

239

1047

Obesity, other/unspecified

136

699

1.95

12.18

1.2

1.3

0.33

0.30

g/l

5.67

108

565

Implicit bacterial Sepsis

113

461

2.11

12.14

1.3

1.2

0.33

0.31

g/l

1.97

369

Brachial plexus disorders

154

3.14

12.05

1.1

1.2

0.31

0.29

g/l

0.79

127

Other shoulder lesions

124

3.41

12.04

1.5

1.2

0.29

g/l

0.16

Factors influencing health status and contact with health services

128

2.79

12.02

1.2

0.29

0.30

g/l

0.69

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

299

1483

1.57

12.01

1.3

1.2

0.31

0.30

g/l

0.86

241

1177

Candidiasis, including avohilmo

119

589

2.03

11.88

1.3

1.2

0.31

0.30

g/l

0.95

100

469

Disorders of synovium and tendon

169

790

1.82

11.86

1.2

0.31

0.30

g/l

1.51

131

636

Crohn disease

216

2.75

11.72

1.5

1.2

0.30

0.29

g/l

0.22

176

Bacterial Sepsis

129

539

1.98

11.71

1.3

1.2

0.33

0.30

g/l

2.26

104

432

Cellulitis

322

2.40

11.64

1.4

1.3

0.34

0.29

g/l

3.58

252

Vasculitis limited to skin, not elsewhere classified

8.75

11.55

1.3

1.2

0.32

0.27

g/l

1.49

Other inflammation of eyelid, including avohilmo

169

948

1.79

11.53

1.3

1.2

0.29

0.30

g/l

1.62

128

770

Cystitis

270

1000

1.61

11.39

1.3

1.2

0.30

g/l

0.56

222

796

Collagenous colitis

134

3.23

11.34

1.3

1.2

0.33

0.29

g/l

1.80

109

Injuries to the abdomen, lower back, lumbar spine and pelvis

128

651

1.94

11.33

1.2

0.30

g/l

0.15

102

529

Other disorders of adrenal gland

4.25

11.28

1.4

1.2

0.33

0.29

g/l

1.59

Budesonide

187

2.85

11.28

1.4

1.2

0.32

0.29

g/l

2.31

144

Constipation

276

1181

1.59

11.27

1.2

1.3

0.32

0.30

g/l

2.14

216

956

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

179

1008

1.74

11.22

1.2

0.31

0.30

g/l

0.85

131

825

Other disorders of bone

334

2.35

11.21

1.3

1.2

0.29

g/l

0.01

271

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

189

955

1.72

11.18

1.3

1.2

0.32

0.30

g/l

2.40

151

779

Falls/tendency to fall

350

1155

1.52

11.16

1.2

0.30

g/l

0.01

282

907

D07AA Corticosteroids, weak (group I)

286

2.46

11.12

1.1

1.3

0.31

0.29

g/l

0.99

233

Infections, IBD-co-morbidities

111

3.11

11.11

1.3

1.2

0.30

0.28

g/l

0.46

Hypothyroidism, drug reimbursement

133

2.90

11.05

1.2

1.3

0.30

0.29

g/l

0.46

109

Diseases of inner ear

162

868

1.79

11.04

1.2

0.31

g/l

0.59

125

710

Exposure to other and unspecified forces of nature

16.47

10.99

1.4

1.2

0.31

0.28

g/l

0.48

Continuous positive airway pressure

174

2.74

10.85

1.1

1.2

0.32

0.30

g/l

1.53

146

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

153

521

1.85

10.83

1.3

1.2

0.30

0.29

g/l

0.39

130

412

Trochanteric bursitis

186

2.81

10.81

1.3

1.2

0.29

0.30

g/l

0.41

142

Other neurological diseases

205

949

1.68

10.76

1.3

1.2

0.30

0.31

g/l

0.23

177

761

Carpal tunnel syndrome

188

957

1.70

10.69

1.2

0.30

0.31

g/l

0.34

158

764

Other symptoms and signs involving the circulatory and respiratory systems

3.85

10.65

1.1

1.2

0.30

g/l

0.10

Metabolic disorders

287

1107

1.56

10.63

1.2

1.3

0.32

0.30

g/l

5.27

230

878

Other disorders of eye and adnexa

257

2.50

10.61

1.1

1.2

0.31

0.30

g/l

0.46

205

Hernia of abdominal wall

135

727

1.86

10.57

1.2

0.30

0.31

g/l

0.06

102

586

Haemorrhage from respiratory passages

351

2.20

10.55

1.2

0.31

0.30

g/l

0.32

280

Panniculitis affecting regions of neck and back

5.06

10.53

1.1

1.3

0.30

0.29

g/l

0.37

Exclusions for E4_PCOS_BROAD

300

2.38

10.52

1.3

1.2

0.31

0.30

g/l

1.04

246

Chronic laryngitis and laryngotracheitis

178

2.82

10.50

1.2

0.32

0.30

g/l

1.01

142

Rosacea

218

2.63

10.45

1.3

1.2

0.29

0.30

g/l

0.41

177

Radiculopathy

173

2.84

10.44

1.4

1.2

0.32

0.31

g/l

0.16

137

Hypermobility syndrome

106

3.43

10.42

1.2

0.31

0.29

g/l

1.21

Insomnia

292

1328

1.53

10.36

1.2

0.30

g/l

0.33

228

1066

Adrenocortical insufficiency

4.32

10.32

1.3

1.1

0.34

0.29

g/l

1.65

All influenza

411

2.15

10.30

1.2

0.30

g/l

0.05

332

Acute laryngitis and tracheitis

177

2.79

10.28

1.4

1.2

0.31

0.29

g/l

0.49

139

Other viral diseases, not elsewhere classified, including avohilmo

111

562

1.97

10.27

1.2

1.3

0.31

0.30

g/l

0.99

461

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

112

3.33

10.26

1.3

1.2

0.34

0.29

g/l

2.45

Endometriosis ASRM stages 1,2

381

2.19

10.17

1.2

0.30

g/l

0.21

314

Stomatitis and related lesions

356

2.23

10.12

1.4

1.2

0.29

0.30

g/l

0.15

283

Ocular pain

144

3.01

10.10

1.1

1.2

0.31

0.29

g/l

0.92

116

Abnormal involuntary movements

200

2.66

9.99

1.2

0.33

0.30

g/l

2.12

162

Fall on same level

368

1342

1.46

9.98

1.3

1.2

0.31

0.30

g/l

1.50

295

1057

Other viral diseases, including avohilmo

148

827

1.78

9.96

1.2

0.30

0.29

g/l

0.25

107

676

Inflammatory bowel disease

111

574

1.94

9.87

1.3

0.30

g/l

0.39

461

Benign thyroid growths and nodules

103

480

2.00

9.87

1.3

1.2

0.31

0.30

g/l

0.63

384

Abnormal findings on diagnostic imaging of lung

124

628

1.87

9.86

1.3

1.2

0.33

0.30

g/l

1.89

515

Injuries to the knee and lower leg

372

1383

1.46

9.85

1.2

0.31

0.30

g/l

0.99

296

1100

Selective serotonin reuptake inhibitors

293

998

1.53

9.74

1.2

0.31

0.30

g/l

0.91

241

793

Congenital malformations of the musculoskeletal system, not elsewhere classified

5.42

9.69

1.2

1.1

0.31

0.30

g/l

0.23

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

115

606

1.90

9.68

1.2

0.32

0.30

g/l

1.52

487

Other and unspecified nerve root and plexus disorders, also in other diseases

319

2.27

9.63

1.2

0.31

0.30

g/l

0.76

253

Nonorganic sleeping disorders, excluding more controls

377

2.16

9.60

1.3

1.2

0.30

0.29

g/l

0.32

310

Internal derangement of knee

109

560

1.93

9.58

1.2

0.31

0.30

g/l

0.74

450

Other inflammation of eyelid

205

2.60

9.53

1.2

0.30

0.31

g/l

0.30

165

Viral infections characterized by skin and mucous membrane lesions

135

753

1.80

9.46

1.4

1.2

0.31

0.30

g/l

0.81

113

609

Other enthesopathies

473

2.01

9.42

1.2

0.29

0.30

g/l

0.55

379

Generalized anxiety disorder

328

2.23

9.42

1.2

0.30

0.29

g/l

0.77

273

L04AA Selective immunosuppressants

381

2.13

9.37

1.2

0.33

0.30

g/l

2.70

305

L04AD Calcineurin inhibitors

167

2.77

9.36

1.1

1.2

0.32

0.29

g/l

1.53

136

Deforming dorsopathies

414

2.08

9.34

1.2

0.29

0.30

g/l

0.56

336

Other disorders of skin and subcutaneous tissue

215

1144

1.59

9.30

1.3

1.2

0.32

0.30

g/l

3.28

171

921

Disorders of skin appendages

177

1065

1.66

9.30

1.2

0.29

0.30

g/l

0.35

130

870

Other gastritis (incl. Duodenitis)

269

2.35

9.19

1.2

0.32

0.31

g/l

0.23

214

Urinary track infection

220

684

1.61

9.18

1.3

1.2

0.30

g/l

0.35

183

541

Injuries to the thorax

129

717

1.80

9.16

1.2

0.32

0.30

g/l

1.34

583

Diseases of oral cavity, salivary glands and jaws

145

414

1.81

9.12

1.2

0.30

g/l

0.28

111

332

Procreative management

120

533

1.86

9.12

1.4

1.2

0.29

0.30

g/l

1.11

435

Other specified/unspecified systemic involvement of connective tissue

3.61

9.11

1.4

1.1

0.30

0.29

g/l

0.24

Gout

224

2.38

9.04

1.1

1.3

0.33

0.31

g/l

1.00

187

Hard cardiovascular diseases

236

893

1.56

8.97

1.2

0.32

0.31

g/l

1.10

190

727

Deviated nasal septum

434

2.03

8.96

1.4

1.2

0.29

0.31

g/l

1.17

352

Any mental disorder

318

1080

1.48

8.96

1.3

1.2

0.31

0.30

g/l

0.90

253

867

Benign paroxysmal vertigo

428

2.04

8.95

1.2

0.30

0.31

g/l

0.46

345

Ovarian cyst

124

380

1.87

8.91

1.3

1.2

0.30

g/l

0.25

304

Crohn's disease of small intestine

102

3.26

8.89

1.5

1.2

0.30

0.29

g/l

0.29

Papulosquamous disorders

121

667

1.82

8.88

1.3

1.2

0.31

0.30

g/l

0.07

100

541

Other diseases of liver

286

2.28

8.87

1.1

1.2

0.31

0.30

g/l

0.19

233

Hypokalaemia

150

2.81

8.83

1.3

0.32

0.30

g/l

0.84

121

Early onset COPD, excluding more controls

213

2.49

8.81

1.3

1.2

0.34

0.30

g/l

2.82

171

Excessive vomiting in pregnancy

179

2.65

8.76

1.2

0.29

g/l

0.09

148

Excessive, frequent and irregular menstruation

137

406

1.81

8.69

1.3

1.2

0.30

g/l

0.04

106

325

Cluster headache, wide

4.27

8.67

1.1

0.29

g/l

0.03

Polyarthrosis

208

2.43

8.65

1.3

1.2

0.30

0.32

g/l

0.72

167

Superficial injury of abdomen, lower back and pelvis

258

2.34

8.65

1.2

0.31

0.30

g/l

0.92

204

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

4.85

8.63

1.2

1.1

0.31

0.30

g/l

0.27

Localized swelling, mass and lump of skin and subcutaneous tissue

505

1.93

8.52

1.3

1.2

0.31

0.30

g/l

0.19

405

Cholecystectomy

208

1130

1.57

8.51

1.3

1.2

0.31

0.30

g/l

0.74

164

908

Diseases of external ear

110

597

1.85

8.51

1.3

1.2

0.30

g/l

0.19

482

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

252

972

1.52

8.39

1.4

1.2

0.31

0.30

g/l

1.59

203

761

252

972

1.52

8.39

1.4

1.2

0.31

0.30

g/l

1.59

203

761

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

146

853

1.69

8.38

1.2

0.30

g/l

0.63

119

688

Benign neoplasm: Colon

136

742

1.72

8.26

1.3

1.2

0.31

g/l

0.09

110

605

Hypothyroidism, strict autoimmune, 3 medication purchases required

257

1155

1.50

8.26

1.2

0.30

g/l

0.06

198

921

Superficial injury of lower leg

476

1.94

8.25

1.2

0.31

0.29

g/l

0.90

380

Mycoses

463

1.95

8.21

1.2

0.31

0.30

g/l

0.85

375

Algoneurodystrophy

4.25

8.21

1.4

1.1

0.28

0.29

g/l

0.23

Cluster headache, wide,, including avohilmo

3.29

8.21

1.2

0.28

0.29

g/l

0.16

Chronic apical periodontitis

340

1341

1.42

8.15

1.3

1.2

0.30

g/l

0.23

267

1072

Diabetes mellitus

315

1263

1.44

8.15

1.2

0.32

0.30

g/l

7.38

252

1005

Obesity due to excess calories

164

1009

1.63

8.14

1.1

1.2

0.32

0.30

g/l

3.42

137

814

Polyneuropathies and other disorders of the peripheral nervous system

259

2.29

8.13

1.3

1.2

0.32

0.30

g/l

0.66

207

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

108

3.08

8.12

1.5

1.2

0.30

0.29

g/l

0.21

Superficial injury of wrist and hand

370

2.06

8.10

1.2

0.30

g/l

0.07

296

Other extrapyramidal and movement disorders in other diseases

370

2.06

8.09

1.2

0.30

0.31

g/l

0.11

297

Other necrotizing vasculopathies

3.40

8.07

1.2

0.36

0.29

g/l

4.33

Recurrent aphthous stomatitis , including avohilmo

229

2.37

8.06

1.5

1.2

0.29

0.30

g/l

0.38

184

Nonsuppurative otitis media, including avohilmo

118

572

1.79

8.04

1.2

0.30

g/l

0.08

100

454

Exposure to other and unspecified inanimate mechanical forces

115

2.98

7.92

1.2

1.1

0.31

0.30

g/l

0.32

Abnormal findings on examination of blood, without diagnosis

124

643

1.75

7.91

1.3

1.2

0.33

0.30

g/l

3.11

103

519

Nontoxic goitre/thyroid nodule

451

1.93

7.79

1.4

1.2

0.31

g/l

0.14

360

Hernia

266

1206

1.47

7.76

1.3

1.2

0.31

0.30

g/l

0.91

211

971

Other peripheral vertigo

122

2.89

7.73

1.2

0.32

0.30

g/l

1.17

100

All influenza (not pneumonia)

221

2.36

7.73

1.3

1.2

0.30

g/l

0.01

173

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

3.51

7.70

1.3

0.34

0.27

g/l

2.49

Diseases of arteries, arterioles and capillaries (FINNGEN)

190

2.26

7.69

1.2

0.32

0.30

g/l

1.26

157

Lichen ruber planus, wide definition including periferal and oral lichen planus

324

2.11

7.69

1.3

1.2

0.31

g/l

0.12

265

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

538

1.85

7.68

1.3

1.2

0.32

0.30

g/l

1.41

439

Glucagon-like peptide-1 (GLP-1) analogues

538

1.85

7.68

1.3

1.2

0.32

0.30

g/l

1.41

439

Use of hypnotics and sedatives

311

1246

1.43

7.66

1.3

1.2

0.32

0.30

g/l

2.48

246

994

Other viral diseases, not elsewhere classified

330

2.09

7.66

1.2

1.3

0.32

0.29

g/l

2.83

273

Diabetes, varying definitions

311

1265

1.43

7.65

1.2

0.32

0.30

g/l

7.18

249

1008

Venous thromboembolism

139

802

1.67

7.63

1.3

1.2

0.33

0.30

g/l

3.60

116

646

Lateral epicondylitis

192

2.46

7.63

1.2

0.30

0.29

g/l

0.12

150

Chondropathies

254

2.25

7.62

1.2

0.30

0.29

g/l

0.26

206

Crohn disease (strict definition, require KELA)

102

3.06

7.58

1.6

1.2

0.30

0.29

g/l

0.20

Polycystic ovarian syndrome, consortium definition

255

990

1.48

7.57

1.2

0.30

g/l

0.13

200

789

Other skin changes

261

2.23

7.57

1.2

0.31

g/l

0.09

206

Disorders of other endocrine glands

138

815

1.67

7.57

1.3

1.2

0.31

0.30

g/l

1.16

109

664

Intestinal adhesions without obstruction

3.11

7.54

1.4

1.3

0.30

g/l

0.16

Viral and other specified intestinal infections

364

2.02

7.54

1.3

1.2

0.30

0.29

g/l

0.31

291

Bell's palsy

158

2.61

7.51

1.4

1.2

0.29

0.30

g/l

0.52

126

Other Crohn's disease

108

2.98

7.50

1.6

1.2

0.31

0.29

g/l

0.64

Neuralgia and neuritis, unspecified

3.68

7.46

1.3

1.2

0.30

0.29

g/l

0.40

Adenomyosis (Endometriosis of uterus)

206

2.38

7.45

1.2

0.32

0.31

g/l

0.27

162

Intracranial injury

173

1025

1.57

7.44

1.2

0.31

0.30

g/l

0.68

139

832

Spinal stenosis

113

469

1.78

7.40

1.1

1.3

0.31

g/l

0.04

379

Rheumatoid arthritis

379

1.94

7.40

1.2

0.33

0.30

g/l

1.88

308

Meniscus derangement

137

538

1.69

7.40

1.3

1.2

0.31

g/l

0.08

107

428

Other erythematous conditions

6.00

7.38

1.2

1.1

0.31

0.29

g/l

0.37

Other symptoms and signs involving cognitive functions and awareness

115

584

1.75

7.35

1.3

0.32

0.31

g/l

0.62

478

Diseases of middle ear and mastoid

190

1007

1.54

7.33

1.3

1.2

0.30

g/l

0.08

163

799

Disorders of gallbladder, biliary tract and pancreas

286

1243

1.43

7.33

1.3

1.2

0.31

0.30

g/l

1.12

228

993

Inflammatory disease of uterus

311

2.10

7.30

1.5

1.2

0.29

g/l

0.00

253

Type 2 diabetes

293

1189

1.43

7.27

1.2

0.32

0.30

g/l

6.71

236

948

Other and unspecified mood [affective] disorders

121

2.83

7.26

1.1

1.2

0.34

0.28

g/l

2.53

100

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

166

1052

1.58

7.26

1.3

0.31

0.30

g/l

0.68

119

865

Benign neoplasms

297

1134

1.43

7.25

1.2

0.30

g/l

0.34

242

905

Disorders of continuity of bone

161

2.56

7.25

1.3

1.2

0.32

0.30

g/l

0.79

137

Tonsillectomy and adenotomy

206

945

1.52

7.22

1.3

1.2

0.29

0.30

g/l

0.73

161

753

Soft tissue disorders related to use, overuse and pressure

387

1.97

7.20

1.2

0.30

g/l

0.02

310

Psychiatric diseases

267

918

1.46

7.19

1.2

0.30

g/l

0.18

212

742

Unspecified fall

149

907

1.61

7.19

1.2

0.31

0.30

g/l

0.12

113

734

Crohn disease (strict definition, require KELA, min 2 HDR)

100

3.02

7.19

1.6

1.2

0.30

0.29

g/l

0.22

Type 2 diabetes, wide definition

207

859

1.52

7.17

1.3

1.2

0.32

0.30

g/l

2.51

160

686

Cluster headache, strict

3.96

7.17

1.1

0.28

0.29

g/l

0.16

Gonarthrosis

156

540

1.63

7.16

1.2

0.31

g/l

0.10

127

433

Misadventures to patients during surgical and medical care

192

2.41

7.15

1.4

1.2

0.31

0.30

g/l

0.16

158

Candidiasis

242

2.24

7.14

1.2

1.3

0.32

0.29

g/l

1.21

198

Diplopia

175

2.47

7.06

1.1

1.2

0.31

0.30

g/l

0.33

139

Paralytic ileus and intestinal obstruction

308

2.08

7.06

1.3

1.2

0.31

g/l

0.18

251

Other bacterial intestinal infections, including avohilmo

329

2.04

7.03

1.3

1.2

0.30

g/l

0.22

270

Cluster headache, strict, including avohilmo

3.10

7.01

1.1

1.2

0.27

0.29

g/l

0.34

Ulcerative colitis, NAS

219

2.29

6.99

1.3

1.2

0.30

g/l

0.22

182

Herpesviral [herpes simplex] infections, including avohilmo

519

1.82

6.98

1.3

1.2

0.31

0.30

g/l

0.48

417

Diverticular disease of intestine

177

705

1.56

6.96

1.3

1.2

0.31

g/l

0.60

139

571

Gout, FINNGEN

295

2.09

6.94

1.1

1.3

0.33

0.30

g/l

1.70

241

Persons encountering health services for specific procedures, not carried out

147

2.60

6.94

1.5

1.3

0.33

0.28

g/l

1.41

118

Heart failure and antihypertensive medication

157

2.28

6.93

1.3

1.2

0.34

0.29

g/l

4.67

131

Insulin, intermediate and long-acting

142

848

1.62

6.91

1.1

1.3

0.34

0.30

g/l

4.58

110

686

Problems related to lifestyle

165

2.50

6.90

1.2

0.34

0.29

g/l

3.81

133

Diseases of liver

543

1.79

6.88

1.2

0.32

0.30

g/l

0.77

446

Fracture of foot, except ankle

457

1.87

6.87

1.2

0.32

0.29

g/l

2.25

366

Disorders of lipoprotein metabolism and other lipidaemias

215

875

1.50

6.85

1.2

0.33

0.30

g/l

3.70

177

699

Lesion of ulnar nerve

184

2.40

6.83

1.3

0.30

g/l

0.03

148

Artrosis, including avohilmo

237

883

1.47

6.83

1.2

0.30

g/l

0.28

190

702

Paroxysmal tachycardia

273

2.04

6.82

1.4

1.2

0.29

g/l

0.21

219

Dental operations

145

452

1.65

6.81

1.2

0.30

0.31

g/l

0.96

111

371

Other and unspecified polyneuropathies, also in other diseases

228

2.24

6.80

1.2

0.32

0.30

g/l

0.54

180

Reimbursement for rheumatic diseases

167

1075

1.55

6.74

1.3

1.2

0.31

0.30

g/l

0.65

135

868

Lichen planus, including avohilmo

268

2.13

6.72

1.3

1.2

0.32

0.31

g/l

0.32

214

Hyperkinetic disorders, excluding more controls

255

2.13

6.72

1.2

0.28

0.29

g/l

0.15

210

Insulin medication

158

835

1.57

6.68

1.1

1.2

0.34

0.30

g/l

4.81

122

675

Hyperlipidaemia, other/unspecified

438

1.83

6.67

1.1

1.3

0.32

0.31

g/l

0.69

352

Sulfasalazine

384

1.93

6.67

1.2

0.32

0.29

g/l

1.61

302

Other congenital malformations

156

2.51

6.66

1.1

1.2

0.29

0.28

g/l

0.14

127

Ventral hernia

330

2.01

6.62

1.3

1.2

0.30

0.31

g/l

0.10

262

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

273

1220

1.42

6.61

1.2

0.31

0.30

g/l

0.10

229

969

Other and unspecified erythematous conditions

5.93

6.61

1.2

1.1

0.31

0.29

g/l

0.62

Extrapyramidal and movement disorders

100

572

1.75

6.61

1.2

0.30

0.31

g/l

0.15

458

Angina pectoris

128

510

1.67

6.60

1.2

1.3

0.32

0.31

g/l

0.46

102

417

Other local infections of skin and subcutaneous tissue

145

2.56

6.59

1.3

1.2

0.30

0.29

g/l

0.14

117

Benign neoplasm of colon, rectum, anus and anal canal

154

828

1.57

6.58

1.3

1.2

0.31

g/l

0.02

123

679

Insulin, fast-acting

565

1.75

6.58

1.1

1.3

0.34

0.29

g/l

4.48

463

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

265

1105

1.42

6.56

1.2

0.32

0.30

g/l

2.97

214

884

Insulin, combination of fast acting with intermediate-acting or long-acting

158

920

1.56

6.56

1.1

1.3

0.34

0.30

g/l

4.45

122

747

Symptoms and signs involving the urinary system

205

1044

1.48

6.53

1.3

1.2

0.30

0.31

g/l

0.67

165

843

Secondary hypertension

3.10

6.52

1.2

1.3

0.33

0.29

g/l

1.05

Dipeptidyl peptidase 4 (DPP-4) inhibitors

128

610

1.65

6.51

1.3

1.2

0.33

0.31

g/l

1.73

104

496

Other septicaemia, including avohilmo

476

1.80

6.50

1.4

1.3

0.33

0.30

g/l

1.60

387

Ischemic heart diseases

216

871

1.48

6.50

1.3

1.2

0.32

0.31

g/l

1.00

172

710

Other disorders of eyelid

108

597

1.71

6.50

1.3

1.2

0.30

0.31

g/l

0.17

490

Fracture of rib(s), sternum and thoracic spine

416

1.88

6.49

1.2

1.3

0.32

0.30

g/l

1.04

341

Disease of hard tissues of teeth, NOS

131

411

1.67

6.48

1.3

1.2

0.31

0.30

g/l

0.13

101

329

Cholelithiasis, broad definition with cholecystitis

246

1144

1.43

6.44

1.3

1.2

0.31

0.30

g/l

1.17

196

913

Conjunctivitis (acute, non atopic)

523

1.77

6.43

1.2

1.3

0.31

0.30

g/l

1.22

412

Nonorganic sleeping disorders

439

1.85

6.42

1.3

1.2

0.30

0.29

g/l

0.15

351

Other bacterial intestinal infections

221

2.22

6.42

1.3

1.2

0.30

g/l

0.05

182

Otitis externa, unspecified

196

2.31

6.40

1.3

1.2

0.32

0.29

g/l

1.27

159

Hypo-osmolality and hyponatraemia

195

2.30

6.35

1.2

1.3

0.31

g/l

0.27

155

Other follicular disorders

125

2.66

6.31

1.4

1.2

0.30

0.29

g/l

0.40

105

Anogenital herpesviral [herpes simplex] infection, including avohilmo

243

2.15

6.27

1.2

0.28

0.29

g/l

0.54

195

Ehlers-Danlos syndrome, including avohilmo

5.14

6.24

1.2

1.1

0.30

0.29

g/l

0.17

Leisure time condition

290

2.04

6.23

1.3

1.2

0.31

0.29

g/l

0.57

228

Speech therapy

387

1.89

6.21

1.1

1.2

0.32

0.30

g/l

0.91

309

Infections with a predominantly sexual mode of transmission, including avohilmo

148

869

1.56

6.20

1.3

1.2

0.28

0.30

g/l

1.73

113

694

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

208

1306

1.45

6.18

1.2

0.30

g/l

0.51

158

1046

Gastric ulcer

168

2.39

6.18

1.3

1.2

0.34

0.31

g/l

1.21

130

Persistent mood disorders

291

2.03

6.17

1.1

1.2

0.32

0.30

g/l

1.43

237

5-aminosalicylic acid

298

2.02

6.16

1.2

0.30

0.29

g/l

0.21

235

Explicit Sepsis, including avohilmo

114

623

1.66

6.15

1.4

1.2

0.33

0.30

g/l

1.86

506

Type 2 diabetes, definitions combined, including avohilmo

271

1119

1.40

6.14

1.3

1.2

0.32

0.30

g/l

5.49

220

893

Umbilical hernia

424

1.84

6.14

1.3

1.2

0.30

g/l

0.04

342

KRA_PSY_EATING, excluding more controls

173

2.36

6.14

1.1

0.30

0.28

g/l

1.11

142

Diseases of the digestive system

115

693

1.65

6.13

1.4

1.3

0.31

0.30

g/l

0.18

568

Sequelae of injuries, of poisoning and of other consequences of external causes

396

1.87

6.12

1.2

1.3

0.31

0.30

g/l

1.27

318

Intestinal stricture

403

1.86

6.12

1.3

1.2

0.31

g/l

0.19

322

Car occupant injured in other and unspecified transport accidents

347

1.94

6.12

1.1

1.3

0.31

0.29

g/l

1.18

281

Diabetes, insulin treatment (Kela reimbursement)

276

1179

1.39

6.11

1.3

1.2

0.32

0.30

g/l

2.53

223

947

Personality disorders, excluding more controls

489

1.78

6.10

1.3

1.2

0.31

0.29

g/l

1.47

400

Other diseases of anus and rectum

409

1.85

6.10

1.3

1.2

0.32

0.30

g/l

1.31

333

Other viral diseases

101

592

1.70

6.08

1.2

0.31

0.29

g/l

0.82

477

Nonsuppurative otitis media

404

1.81

6.07

1.2

0.30

0.29

g/l

0.26

318

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

110

656

1.66

6.02

1.3

1.2

0.31

0.29

g/l

1.47

533

Speech disturbances, not elsewhere classified

111

2.72

6.01

1.3

0.30

g/l

0.06

Other septicaemia

463

1.77

6.00

1.4

1.3

0.33

0.30

g/l

1.39

376

Otitis externa

406

1.85

6.00

1.2

0.31

0.30

g/l

0.80

324

Second line medication for Crohn's disease

172

1153

1.49

5.95

1.2

0.31

0.30

g/l

1.36

146

922

Anogenital herpesviral [herpes simplex] infection

129

2.58

5.95

1.3

1.2

0.28

g/l

0.01

101

Chronic gastritis

316

1.97

5.93

1.3

1.2

0.30

0.31

g/l

0.64

251

Cholelithiasis

234

1125

1.42

5.93

1.3

1.2

0.31

0.30

g/l

1.44

188

897

Diabetes medication

302

1293

1.36

5.89

1.2

0.32

0.30

g/l

5.27

237

1036

Major coronary heart disease event

208

856

1.45

5.85

1.3

1.2

0.32

0.31

g/l

1.50

168

700

Scleritis and episcleritis

2.83

5.83

1.2

0.33

0.29

g/l

1.52

Superficial injury of head

360

1.89

5.81

1.2

0.30

g/l

0.06

294

Other female pelvic inflammatory diseases

278

2.02

5.79

1.2

0.31

0.30

g/l

0.27

222

Insulin, fast-acting or short human

588

1.69

5.77

1.1

1.3

0.34

0.30

g/l

4.31

478

Explicit Sepsis

109

603

1.65

5.75

1.4

1.2

0.32

0.30

g/l

1.51

488

Biological medication for rheuma

341

1.91

5.74

1.3

1.2

0.30

0.29

g/l

0.63

277

Nutritional anaemias

130

788

1.57

5.74

1.2

1.3

0.32

0.30

g/l

1.66

101

649

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

530

1.72

5.73

1.2

0.31

0.29

g/l

1.06

434

Percutaneous Coronary Intervention

197

820

1.46

5.72

1.3

1.2

0.32

0.31

g/l

1.07

159

671

Other diseases of hard tissues of teeth

129

413

1.62

5.71

1.2

0.30

0.31

g/l

0.61

331

Coronary revascularization (ANGIO or CABG)

197

820

1.46

5.68

1.3

1.2

0.32

0.31

g/l

1.14

159

671

Septicaemia

523

1.69

5.67

1.4

1.2

0.33

0.30

g/l

1.49

425

Emergency coronary revascularization (for ACS)

207

865

1.45

5.66

1.3

1.2

0.32

0.31

g/l

1.04

165

705

Polyp of the female genital tract

292

1.77

5.65

1.3

1.2

0.30

0.31

g/l

0.51

234

Other and unspecified iron deficiency

546

1.70

5.63

1.3

1.2

0.32

0.30

g/l

0.96

449

Noninflammatory disorders of female genital tract

131

409

1.61

5.63

1.3

1.2

0.29

0.30

g/l

1.34

100

327

Substance abuse, excluding more controls

152

837

1.52

5.62

1.2

0.33

0.30

g/l

4.56

123

683

Impetigo

3.12

5.62

1.5

1.2

0.30

0.29

g/l

0.27

Gout, unspecified

202

2.18

5.57

1.1

1.3

0.33

0.30

g/l

1.11

163

Coxibs

180

1.96

5.54

1.1

1.2

0.29

0.30

g/l

0.35

145

Postprocedural disorders of nervous system

146

2.41

5.54

1.2

0.31

0.28

g/l

0.83

117

Other and unspecified local infections of skin and subcutaneous tissue

140

2.44

5.52

1.3

0.30

0.29

g/l

0.16

114

Fentanyl

2.84

5.48

1.4

1.3

0.33

0.30

g/l

0.86

Other congenital malformations of skin

3.16

5.47

1.2

1.1

0.28

0.30

g/l

0.53

Fall on and from stairs and steps

419

1.79

5.46

1.1

1.3

0.32

0.30

g/l

1.25

331

Gonarthrosis [arthrosis of knee](FG)

180

703

1.47

5.42

1.2

0.31

g/l

0.39

149

574

Type 2 diabetes, definitions combined

263

1114

1.37

5.40

1.3

1.2

0.32

0.30

g/l

5.15

214

888

Exclusions for E4_PCOS_CONSORTIUM

235

1051

1.40

5.38

1.3

1.2

0.31

0.30

g/l

1.15

195

828

Type 2 diabetes, strict (exclude DM1)

263

1115

1.37

5.37

1.3

1.2

0.32

0.30

g/l

5.06

214

889

Other diseases of pleura

499

1.67

5.37

1.4

1.3

0.33

0.31

g/l

2.24

405

Infections with a predominantly sexual mode of transmission

111

692

1.60

5.35

1.3

1.2

0.28

0.29

g/l

1.37

562

Cramp and spasm

3.11

5.34

1.3

1.2

0.32

0.29

g/l

0.68

Appendectomy

197

1320

1.42

5.32

1.3

1.2

0.31

0.30

g/l

0.58

152

1057

IBD patients in KELA-register

409

1.79

5.28

1.3

1.2

0.30

0.29

g/l

0.37

334

Other metabolic disorders

234

2.06

5.25

1.2

1.3

0.32

0.29

g/l

1.30

188

Postprocedural endocrine and metabolic disorders, not elsewhere classified

221

2.09

5.23

1.2

0.32

0.29

g/l

1.22

177

COPD, hospital admission 2, with asthma infections

307

1.85

5.22

1.3

0.34

0.31

g/l

2.84

250

Congenital malformations, deformations and chromosomal abnormalities

188

1249

1.43

5.22

1.3

1.2

0.30

g/l

0.14

143

997

Specific personality disorders

477

1.72

5.22

1.2

0.32

0.29

g/l

2.11

382

COPD

426

1.70

5.21

1.3

0.34

0.31

g/l

3.09

340

Psoriasis

455

1.74

5.20

1.3

0.31

0.30

g/l

0.25

365

Gout, idiopatic and unspecified

262

1.99

5.19

1.2

1.3

0.33

0.30

g/l

1.27

212

Blepharochalasis

382

1.81

5.19

1.3

1.2

0.29

0.31

g/l

1.13

313

Ganglion

332

1.87

5.18

1.2

0.31

0.29

g/l

1.17

266

Oter anti-inflammatory and antirheumatic agents, non-steroids

119

2.17

5.18

1.2

0.30

0.31

g/l

0.22

Nontoxic multinodular goitre

242

2.03

5.17

1.2

0.31

g/l

0.01

196

Mycoses, including avohilmo

269

1518

1.35

5.17

1.3

1.2

0.31

0.30

g/l

0.63

222

1200

Ischaemic heart disease, wide definition

180

762

1.45

5.16

1.3

1.2

0.32

0.31

g/l

1.35

145

625

Psoriasis vulgaris

284

1.94

5.13

1.3

0.31

0.30

g/l

0.40

231

Other and unspecified disorders of vitreous body

106

647

1.60

5.13

1.3

1.2

0.30

0.31

g/l

0.84

530

Gout, strict definition

177

2.21

5.11

1.2

1.3

0.32

0.30

g/l

0.73

137

Disorders of vitreous body

126

779

1.54

5.10

1.2

0.31

g/l

0.16

636

Other disorders involving the immune mechanism, not elsewhere classified

3.78

5.10

1.3

1.2

0.30

g/l

—

Suppurative and unspecified otitis media

121

689

1.56

5.09

1.3

1.2

0.30

0.29

g/l

0.01

101

548

Diseases of pulp and periapical tissues, including avohilmo

289

1112

1.34

5.08

1.2

0.30

g/l

0.26

226

902

Other disorders of the musculoskeletal system and connective tissue

204

2.11

5.05

1.1

1.3

0.32

0.30

g/l

0.67

164

Fracture at wrist and hand level

601

1.63

5.05

1.2

0.30

g/l

0.08

477

Nonalcoholic fatty liver disease

159

2.27

5.04

1.1

1.2

0.31

0.30

g/l

0.48

132

Polyuria

300

1.90

5.03

1.3

0.30

g/l

0.13

241

DVT of lower extremities and pulmonary embolism

579

1.64

5.00

1.2

1.3

0.33

0.30

g/l

3.47

469

L04AX Other immunosuppressants

162

1116

1.45

4.98

1.2

1.3

0.31

0.30

g/l

1.24

138

891

Injuries to the head

321

1449

1.31

4.98

1.3

1.2

0.31

0.30

g/l

0.35

260

1147

Bacterial intestinal infections, IBD co-morbidities

246

2.00

4.96

1.3

1.2

0.31

0.30

g/l

0.06

198

Fenamates

118

2.26

4.96

1.2

0.31

0.30

g/l

0.36

Disturbance of activity and attention

301

1.89

4.96

1.2

0.28

0.29

g/l

0.39

240

Neuromuscular dysfunction of bladder

111

2.53

4.95

1.2

1.3

0.33

0.30

g/l

0.72

Disorders of vitreous body and globe

128

795

1.52

4.95

1.2

0.31

g/l

0.02

101

649

Influenza and pneumonia

309

1447

1.32

4.92

1.3

1.2

0.31

0.30

g/l

0.99

245

1154

Other (not insulin) diabetes medications

268

1168

1.35

4.91

1.3

1.2

0.32

0.30

g/l

3.62

214

936

Atrial fibrillation and flutter with reimbursement

172

1.98

4.90

1.3

1.2

0.33

0.30

g/l

1.37

142

Plantar fascial fibromatosis

136

2.36

4.89

1.2

0.32

0.29

g/l

1.20

108

Amenorrhoea

130

2.40

4.88

1.2

0.30

0.29

g/l

0.23

107

Other diseases of oesophagus

100

2.61

4.88

1.1

1.2

0.32

0.30

g/l

0.70

Psychotic depression

2.93

4.87

1.2

0.31

0.29

g/l

0.36

Ulcer of lower limb, not elsewhere classified

149

2.29

4.85

1.2

1.3

0.36

0.30

g/l

3.23

114

Benign neoplasm of mouth and pharynx

143

2.32

4.83

1.4

1.2

0.31

0.30

g/l

0.38

116

Childhood allergy (age < 16)

266

1.87

4.82

1.1

1.2

0.29

g/l

0.16

213

Seronegative rheumatoid arthritis

137

2.34

4.81

1.2

0.31

g/l

0.17

118

Female infertility

349

1.65

4.81

1.1

1.2

0.30

g/l

0.22

279

Pure hypercholesterolaemia

178

788

1.44

4.81

1.3

1.2

0.32

0.30

g/l

2.50

147

632

Neoplasms

240

920

1.37

4.78

1.2

0.30

g/l

0.27

206

733

Herpesviral [herpes simplex] infections

183

2.14

4.74

1.5

1.2

0.32

0.30

g/l

0.66

149

Acute nasopharyngitis (common cold)

137

2.32

4.72

1.3

1.2

0.31

0.30

g/l

0.35

105

Genitourinary diseases

143

476

1.51

4.72

1.2

0.29

0.30

g/l

0.81

116

374

Nasal polyp

231

2.00

4.67

1.2

0.30

g/l

0.02

186

Inflammatory bowel disease, strict (require KELA)

425

1.72

4.67

1.3

1.2

0.30

0.29

g/l

0.39

347

Other disorders starting during childhood or adolecense, excluding more controls

2.88

4.67

1.4

1.1

0.27

0.29

g/l

0.34

Dislocation, sprain and strain of joints and ligaments of knee

186

1201

1.40

4.66

1.3

1.2

0.30

g/l

0.18

149

961

Emotionally unstable personality disorder

273

1.91

4.66

1.1

1.2

0.33

0.29

g/l

2.67

220

Female infertility, cervical, vaginal, other or unspecified origin

343

1.66

4.65

1.2

0.30

g/l

0.28

276

Myocardial infarction, without ST-elevation

396

1.71

4.63

1.1

1.3

0.33

0.31

g/l

1.69

322

Disorders of adult personality and behaviour

610

1.59

4.62

1.2

0.31

0.29

g/l

1.28

499

Hypopituitarism

109

2.49

4.62

1.3

1.2

0.33

0.29

g/l

1.14

Missing teeth due to accident, extraction or parodontitis

153

944

1.45

4.61

1.3

1.2

0.30

0.31

g/l

0.45

118

768

Iron deficiency anaemia

109

691

1.55

4.59

1.3

1.2

0.32

0.30

g/l

1.23

565

Other chronic obstructive pulmonary disease

408

1.67

4.59

1.3

0.34

0.31

g/l

2.79

327

All kidney diseases

281

1428

1.32

4.59

1.3

1.2

0.32

0.30

g/l

3.35

214

1151

Dialysis, with operation codes

153

2.23

4.58

1.3

0.33

0.30

g/l

0.75

124

Glomerular diseases

247

1.95

4.56

1.2

1.3

0.34

0.30

g/l

2.10

200

Familial hypercholesterolemia

147

2.25

4.55

1.1

1.3

0.36

0.31

g/l

3.09

115

Zoster [herpes zoster], including avohilmo

130

845

1.49

4.51

1.3

1.2

0.31

0.30

g/l

0.49

106

687

Amputation of toe

3.06

4.51

1.1

1.3

0.37

0.29

g/l

2.62

Bleeding

201

1021

1.38

4.48

1.2

0.31

0.30

g/l

0.98

157

831

Spondylolisthesis/Spondylolysis

235

1.96

4.47

1.1

1.2

0.30

0.31

g/l

0.31

185

Other congenital malformations, including avohilmo

249

1.93

4.46

1.3

1.2

0.29

g/l

0.18

204

Glomerular disorders in diseases classified elsewhere

142

2.26

4.46

1.2

0.32

0.29

g/l

0.95

113

Pain associated with micturition

188

2.08

4.44

1.3

0.30

g/l

0.01

151

Special screening examination for other diseases and disorders

111

2.44

4.44

1.2

0.30

g/l

0.00

Other and unspecified injuries of ankle and foot

2.94

4.44

1.2

0.28

g/l

0.13

Paracetamol or NSAID medication

2.21

4.43

1.2

0.28

0.29

g/l

0.36

Mental and behavioural disorders due to psychoactive substance use

158

1015

1.43

4.42

1.2

0.33

0.30

g/l

4.16

127

823

Hyperkinetic disorders

320

1.80

4.42

1.2

0.28

0.29

g/l

0.37

255

Transplanted organ and tissue status

130

2.32

4.42

1.1

1.2

0.34

0.30

g/l

2.09

105

Diseases of arteries, arterioles and capillaries

144

724

1.46

4.40

1.2

0.32

0.31

g/l

1.10

125

580

Deep bite

188

2.02

4.40

1.3

1.2

0.29

g/l

0.00

157

Nephropathy related operations

150

2.21

4.36

1.4

1.2

0.32

0.30

g/l

0.44

120

Cerebral palsy and other paralytic syndromes

163

2.15

4.36

1.2

0.32

0.30

g/l

1.40

133

Superficial injury of thorax

217

1.99

4.34

1.1

1.2

0.32

0.30

g/l

1.37

176

Other (seronegative) rheumatoid arthritis, wide

266

1.88

4.33

1.2

0.32

0.31

g/l

0.85

210

Substance abuse

152

988

1.43

4.33

1.2

0.33

0.30

g/l

4.66

123

804

Other disorders of skin and subcutaneous tissue, not elsewhere classified

190

2.06

4.33

1.2

0.32

0.30

g/l

1.68

149

Acute appendicitis

200

1362

1.36

4.31

1.3

1.2

0.30

g/l

0.42

145

1092

Injuries to the shoulder and upper arm

227

1306

1.34

4.29

1.3

1.2

0.31

0.30

g/l

0.14

181

1054

Other bursopathies

151

2.19

4.29

1.4

1.3

0.30

g/l

0.02

117

Reactive arthropathies

2.54

4.29

1.7

1.2

0.30

g/l

0.05

Early onset COPD

289

1.84

4.26

1.3

0.34

0.30

g/l

2.62

232

Benign neoplasm: Pituitary gland, craniopharyngeal duct

2.71

4.25

1.2

1.1

0.33

0.29

g/l

0.97

Rheumatoid arthritis, including avohilmo

608

1.57

4.24

1.2

0.32

0.30

g/l

2.20

485

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

467

1.61

4.21

1.3

1.2

0.28

0.29

g/l

0.47

378

Appendicitis, broad definition

209

1390

1.35

4.21

1.3

1.2

0.30

g/l

0.23

151

1116

Other diseases of the respiratory system

227

1.94

4.18

1.4

1.3

0.33

0.31

g/l

1.36

182

Other respiratory disorders and diseases

227

1.94

4.18

1.4

1.3

0.33

0.31

g/l

1.36

182

Lichen planus

166

2.12

4.18

1.3

0.30

g/l

0.01

133

Acute appendicitis, no complications

165

1175

1.40

4.17

1.3

1.2

0.30

g/l

0.35

121

957

Diseases of appendix

210

1396

1.35

4.15

1.3

1.2

0.30

g/l

0.15

152

1122

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

502

1.62

4.14

1.4

1.2

0.32

0.30

g/l

1.57

408

Tumor necrosis factor alpha inhibitors

314

1.79

4.13

1.3

1.2

0.30

0.29

g/l

0.60

254

Other CVD (FINNGEN)

2.45

4.12

1.0

1.3

0.33

0.30

g/l

0.98

Acute suppurative otitis media

533

1.58

4.11

1.2

0.29

g/l

0.05

425

Atrial fibrillation and flutter

255

1.72

4.10

1.3

1.2

0.32

0.30

g/l

1.84

211

Restless leg syndrome

229

1.93

4.09

1.1

1.2

0.29

0.30

g/l

0.51

184

Acetic acid derivatives and related substances

171

1.82

4.09

1.3

1.2

0.29

0.30

g/l

0.64

139

Ulcerative colitis

412

1.68

4.08

1.2

1.3

0.31

0.29

g/l

0.76

336

Osteoporosis

295

1.78

4.08

1.2

0.33

0.32

g/l

0.62

243

Maternal care for other conditions predominantly related to pregnancy

529

1.59

4.08

1.2

0.30

g/l

0.23

427

Disorders of sclera, cornea, iris and ciliary body

151

1072

1.41

4.05

1.3

0.31

0.30

g/l

0.38

128

858

Diseases of pulp and periapical tissues and dental caries

156

560

1.43

4.04

1.2

0.30

g/l

0.23

123

453

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

280

1368

1.29

4.00

1.2

0.32

0.30

g/l

4.06

214

1104

Benign neoplasm: Small intestine

3.91

3.99

1.2

0.34

0.29

g/l

—

Other/unspecified synovitis and tenosynovitis

143

2.17

3.98

1.1

1.2

0.30

0.29

g/l

0.13

111

Biguanides

252

1160

1.31

3.97

1.3

1.2

0.32

0.30

g/l

2.40

202

931

Hidradenitis suppurativa

2.83

3.96

1.1

0.32

0.29

g/l

0.84

Benign neoplasm: Colon, unspecified

311

1.77

3.95

1.3

0.31

g/l

0.01

250

Pregnancy examination and test

257

1.69

3.94

1.3

1.2

0.29

0.30

g/l

0.51

210

Caries of enamel

272

1375

1.29

3.94

1.2

0.30

g/l

0.17

227

1085

Other and unspecified anaemias

528

1.57

3.93

1.4

1.2

0.33

0.31

g/l

1.97

427

Eating disorder

218

1.93

3.93

1.1

1.3

0.30

0.28

g/l

0.99

173

Spondylopathies (FG)

205

1.96

3.90

1.5

1.2

0.29

g/l

0.24

171

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

106

2.37

3.90

1.5

1.2

0.29

g/l

0.00

Impingement syndrome of shoulder

328

1.74

3.87

1.3

1.2

0.31

0.30

g/l

0.24

261

Mouth breathing

100

662

1.51

3.84

1.2

0.32

0.30

g/l

1.36

544

Cerebrovascular diseases

162

808

1.39

3.83

1.2

0.32

0.31

g/l

1.27

131

661

Episcleritis

2.49

3.80

1.2

0.34

0.29

g/l

1.72

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

264

1.82

3.79

1.2

1.3

0.31

0.30

g/l

0.36

215

Infective dermatitis

133

2.19

3.79

1.6

1.2

0.32

0.30

g/l

0.44

111

Gingivitis and periodontal diseases

258

1023

1.30

3.78

1.2

0.30

g/l

0.11

212

808

Anomalies of dental arch relationship, including avohilmo

380

1.65

3.76

1.3

1.2

0.29

g/l

0.01

309

Chronic kidney disease

340

1.70

3.74

1.1

1.3

0.37

0.30

g/l

5.75

277

Any death

738

0.61

3.73

1.2

1.3

0.34

0.31

g/l

1.94

596

Other anaemias

534

1.54

3.71

1.4

1.2

0.33

0.31

g/l

2.00

433

Carbimazole or st.post thyroidectomy, condition for graves disease

378

1.67

3.70

1.1

1.2

0.31

0.30

g/l

0.81

305

Peripheral artery operations in Hilmo

115

2.26

3.69

1.1

1.3

0.36

0.30

g/l

2.40

Achilles tendinitis

122

2.22

3.66

1.3

1.2

0.29

0.31

g/l

1.07

Otitis media, unspecified

199

1.90

3.66

1.4

1.2

0.29

g/l

0.15

157

Chronic pancreatitis

155

2.07

3.66

1.3

0.34

0.30

g/l

1.85

122

Vestibular neuronitis

116

2.25

3.64

1.3

0.34

0.30

g/l

1.38

Aplastic and other anaemias

576

1.51

3.63

1.4

1.2

0.33

0.31

g/l

2.12

469

Additional codes for the location of defect, injury or illness

2.48

3.63

1.0

1.2

0.33

0.29

g/l

1.13

Substance use, excluding alcohol

343

1.69

3.60

1.2

0.32

0.29

g/l

2.43

277

Uterine polyps

280

1.61

3.58

1.3

1.2

0.30

0.31

g/l

0.17

225

Personality disorders

570

1.53

3.57

1.3

0.31

0.29

g/l

1.20

462

Other symptoms and signs involving the urinary system

130

2.16

3.57

1.2

1.3

0.37

0.30

g/l

2.12

101

Other maternal disorders predominantly related to pregnancy

185

860

1.35

3.56

1.2

0.31

0.30

g/l

0.73

150

684

Zoster [herpes zoster]

248

1.82

3.56

1.7

1.2

0.29

0.30

g/l

0.39

197

Cerebral aneurysm, nonruptured

111

2.26

3.54

1.2

0.31

0.30

g/l

0.21

Ptosis of eyelid

131

2.14

3.50

1.4

1.2

0.31

g/l

0.03

107

Volume depletion

2.33

3.49

1.2

1.3

0.32

0.30

g/l

0.40

Haemorrhoids and perianal venous thrombosis

482

1.57

3.48

1.2

0.31

0.30

g/l

0.21

391

Spontaneous abortion

147

709

1.39

3.48

1.2

0.30

g/l

0.44

119

575

Reactive arthropathies, FINNGEN

2.38

3.48

1.7

1.2

0.29

0.30

g/l

0.05

Fall on same level involving ice and snow

152

1112

1.37

3.46

1.3

1.2

0.31

0.30

g/l

0.39

121

903

Eating disorders

236

1.83

3.44

1.1

1.3

0.30

0.28

g/l

0.82

190

Disorders of refraction and accommodation

589

1.51

3.43

1.3

1.2

0.31

0.30

g/l

0.60

478

Disorders of ocular muscles, binocular movement, accommodation and refraction

146

1054

1.37

3.43

1.3

1.2

0.31

0.30

g/l

0.81

101

855

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

139

2.09

3.42

1.2

0.31

0.29

g/l

0.65

111

Phlebitis and thrombophlebitis (not including DVT)

341

1.67

3.41

1.3

1.2

0.32

0.31

g/l

1.10

272

Sacroiliitis, not elsewhere classified

2.67

3.39

1.7

1.3

0.29

0.28

g/l

0.16

Methotrexate

167

1.98

3.38

1.1

1.2

0.31

0.29

g/l

0.53

129

Thyroiditis, ILD-related definition

195

1.90

3.37

1.3

1.2

0.29

g/l

0.04

155

Benign neoplasm of other and unspecified endocrine glands

195

1.90

3.37

1.3

0.32

0.30

g/l

0.55

159

Other congenital malformations of skin, including avohilmo

147

2.05

3.35

1.4

1.2

0.29

g/l

0.09

119

Unspecified kidney failure

101

2.28

3.35

1.1

1.3

0.36

0.29

g/l

2.70

Other or unspecified ileus, impaction or obstruction

210

1.86

3.33

1.4

1.2

0.32

0.31

g/l

0.30

171

Viral warts, including avohilmo

413

1.60

3.33

1.2

0.31

0.29

g/l

0.88

332

Other disorders of kidney and ureter

175

1.95

3.32

1.0

1.3

0.30

g/l

0.05

138

Mixed and other personality disorders

141

2.07

3.31

1.5

1.2

0.31

0.29

g/l

0.69

115

Abscess of anal and rectal regions

121

2.16

3.31

1.3

1.2

0.33

0.29

g/l

1.07

101

Benign neoplasm: Transverse colon

121

2.16

3.31

1.3

0.31

0.30

g/l

0.19

Conduction disorders

316

1.62

3.31

1.3

1.2

0.30

0.31

g/l

0.30

255

Kidney transplant status

2.63

3.30

1.0

1.2

0.35

0.29

g/l

2.04

Other diseases of the digestive system

406

1.60

3.30

1.4

1.3

0.31

g/l

0.01

331

Left bundle-branch block

2.62

3.30

1.5

1.2

0.28

0.30

g/l

0.29

Hypertrophy of breast in women and men

383

1.62

3.30

1.4

1.2

0.30

g/l

0.03

307

Sequelae of injuries of head

2.55

3.29

1.5

1.2

0.31

0.29

g/l

0.47

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

210

1.85

3.28

1.1

1.2

0.30

0.28

g/l

0.58

174

COPD, hospital admissions 3, with asthma pneumonia sepsis

223

1.77

3.28

1.4

1.2

0.34

0.31

g/l

1.54

178

Superficial injury of hip and thigh

197

1.88

3.28

1.1

1.2

0.32

0.30

g/l

0.49

158

Prolonged pregnancy

388

0.46

3.27

1.0

1.2

0.28

0.29

g/l

0.49

318

Gastroduodenal ulcer

269

1.74

3.27

1.3

0.35

0.31

g/l

1.73

216

Fibroblastic disorders

285

1.72

3.26

1.2

0.33

0.30

g/l

1.95

221

Spondyloarthritis

271

1.74

3.23

1.5

1.2

0.31

0.30

g/l

0.34

214

Sequelae of injuries of neck and trunk

3.36

3.23

1.0

1.2

0.32

0.28

g/l

1.30

Other hammer toe(s) (acquired)

160

1.94

3.23

1.3

1.2

0.30

0.32

g/l

0.54

132

Necrosis of pulp, including avohilmo

170

1266

1.33

3.22

1.2

0.31

0.30

g/l

0.59

122

1031

Seropositive rheumatoid arthritis

315

1.68

3.20

1.1

1.2

0.33

0.31

g/l

1.28

257

Amputation

2.27

3.18

1.1

1.3

0.36

0.29

g/l

2.56

COPD-related respiratory insufficiency

110

2.19

3.18

1.1

1.3

0.34

0.30

g/l

1.90

Senile cataract

132

576

1.39

3.17

1.2

1.3

0.33

0.31

g/l

1.78

104

476

Poisoning by drugs, medicaments and biological substances

466

1.55

3.16

1.1

1.2

0.32

0.29

g/l

1.57

378

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

3.27

3.14

1.4

1.2

0.30

g/l

—

Metatarsalgia

124

2.10

3.13

1.1

1.2

0.29

g/l

0.05

Acute renal failure

244

1.77

3.13

1.2

0.35

0.30

g/l

2.78

201

Periodontitis

257

1298

1.26

3.13

1.2

0.32

0.30

g/l

2.10

205

1039

Other chronic obstructive pulmonary disease, including avohilmo

105

601

1.44

3.12

1.3

0.34

0.31

g/l

4.09

488

COPD, early/later onset

464

1.50

3.11

1.3

0.34

0.31

g/l

2.63

375

Other enthesopathy of foot (+metatarsalgia)

138

2.03

3.10

1.1

1.2

0.29

g/l

0.04

109

GI-bleeding

405

1.58

3.10

1.3

0.31

g/l

0.17

330

Other respiratory diseases principally affecting the interstitium

194

1.86

3.09

1.3

0.34

0.30

g/l

1.56

158

Overexertion and strenuous or repetitive movements

152

1.98

3.09

1.3

1.2

0.31

0.29

g/l

0.47

125

Fracture of lumbar spine and pelvis

267

1.72

3.07

1.2

0.31

g/l

0.27

211

Benign neoplasm of other and ill-defined parts of digestive system

246

1.75

3.05

1.2

0.32

0.30

g/l

0.73

195

Ankylosing spondylitis

2.23

3.05

1.3

1.2

0.31

0.30

g/l

0.24

Open wound of lower leg

217

1.80

3.04

1.2

0.33

0.29

g/l

2.06

174

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

130

2.05

3.04

1.1

1.2

0.30

0.29

g/l

0.63

106

Tinnitus

353

1.62

3.03

1.2

0.29

0.30

g/l

0.61

291

Chronic periodontitis, complicated

133

951

1.36

3.02

1.2

0.32

0.31

g/l

1.66

105

775

Menorrhagia

342

1.49

3.02

1.2

0.30

g/l

0.01

276

Crushed, pushed or stepped on by crowd or human stampede

133

2.04

3.01

1.3

1.2

0.30

0.29

g/l

0.32

111

COPD, hospital admissions

463

1.49

3.00

1.3

0.34

0.31

g/l

2.43

374

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

635

1.45

2.99

1.2

0.31

0.30

g/l

0.71

513

Injuries to the hip and thigh

107

679

1.41

2.98

1.1

1.3

0.32

0.30

g/l

0.78

549

Unstable angina pectoris

325

1.57

2.97

1.2

1.3

0.33

0.31

g/l

0.74

261

Fissure and fistula of anal and rectal regions

355

1.61

2.97

1.2

0.32

0.30

g/l

0.99

285

Poisoning by medicine

418

1.56

2.96

1.1

1.3

0.32

0.29

g/l

1.74

339

Chronic periodontitis, including avohilmo

255

1298

1.25

2.96

1.2

0.32

0.30

g/l

2.06

205

1038

Hypertensive heart and/or renal disease

152

1.83

2.95

1.2

1.3

0.33

0.30

g/l

1.59

123

Superficial injury of forearm

169

1.90

2.94

1.2

0.31

0.29

g/l

1.02

139

Nummular dermatitis

2.28

2.93

1.2

1.3

0.33

0.30

g/l

1.06

Caries of dentine, including avohilmo

183

713

1.31

2.93

1.2

0.31

0.30

g/l

0.16

145

571

Stroke, including SAH

126

657

1.38

2.92

1.2

1.3

0.32

0.31

g/l

1.02

101

533

Dental caries, including avohilmo

166

639

1.33

2.92

1.2

0.30

g/l

0.05

131

511

Obsessive-compulsive disorder

121

2.07

2.92

1.3

0.28

g/l

0.28

FESS (DNB20)

191

1.84

2.91

1.2

0.29

0.30

g/l

0.49

158

Pulmonary heart disease, diseases of pulmonary circulation

420

1.55

2.90

1.2

1.3

0.33

0.31

g/l

1.61

338

Visual field defects

108

2.14

2.90

1.1

1.2

0.31

0.30

g/l

0.27

Mental and behavioural disorders due to alcohol

122

847

1.37

2.90

1.2

0.33

0.30

g/l

3.43

689

Acute lymphadenitis

2.22

2.89

1.3

1.2

0.32

0.28

g/l

1.90

ILD, hospital admissions 1, main diag only

142

1.98

2.89

1.3

0.34

0.30

g/l

1.35

110

Salpingitis and oophoritis

296

1.66

2.89

1.3

1.1

0.31

0.30

g/l

0.39

240

Aneurysms, operations, SAH

199

1.81

2.88

1.3

0.31

0.30

g/l

0.12

159

Injuries involving multiple body regions

2.60

2.87

1.3

1.1

0.35

0.28

g/l

—

Trigger finger

192

1.83

2.87

1.3

1.2

0.32

0.30

g/l

0.70

149

Unspecified urinary incontinence

122

2.06

2.86

1.1

1.2

0.30

g/l

0.10

100

3.18

2.85

1.2

0.31

0.28

g/l

—

Congenital malformations and deformations of the musculoskeletal system

170

1.88

2.85

1.1

1.2

0.30

0.28

g/l

0.76

143

Pulmonary heart disease

391

1.56

2.83

1.2

1.3

0.33

0.31

g/l

1.36

312

Pulmonary embolism

391

1.56

2.83

1.2

1.3

0.33

0.31

g/l

1.37

312

Alcohol use disorder, ICD-based

676

1.42

2.82

1.1

1.3

0.34

0.30

g/l

4.59

542

Myocardial infarction

433

1.45

2.82

1.2

1.3

0.33

0.31

g/l

1.40

354

Bitten or struck by other mammals

230

1.74

2.82

1.2

0.30

0.29

g/l

0.95

188

Coxarthrosis

426

1.44

2.80

1.2

1.3

0.31

g/l

0.12

345

Injury of muscle and tendon at lower leg level

223

1.75

2.80

1.3

0.30

0.29

g/l

0.46

181

COPD related to multimorbidity

397

1.51

2.79

1.3

0.34

0.31

g/l

1.81

324

Ischaemic Stroke, excluding all haemorrhages

107

562

1.40

2.79

1.2

1.3

0.32

0.31

g/l

1.18

456

Mental and behavioural disorders due to alcohol, excluding acute intoxication

101

713

1.41

2.79

1.1

1.3

0.34

0.30

g/l

4.45

574

Type 1 diabetes

416

1.54

2.78

1.0

1.2

0.33

0.29

g/l

2.65

338

Peritonsillar abscess

346

1.59

2.77

1.3

1.2

0.32

0.30

g/l

0.87

283

Other/unspecified rheumatoid arthritis

145

1.94

2.74

1.3

1.2

0.32

0.30

g/l

0.63

117

Lower leg

6.11

2.71

1.0

1.1

0.37

0.30

g/l

—

Other/unspecified reactive arthropathies

2.15

2.70

1.7

1.2

0.30

0.29

g/l

0.10

Type 1 diabetes, wide definition, subgroup 1

356

1.57

2.70

1.1

1.2

0.32

0.29

g/l

1.95

289

Endometriosis of ovary

269

1.65

2.70

1.2

0.30

g/l

0.05

214

Other disorders starting during childhood or adolescence

2.15

2.70

1.4

1.2

0.27

0.29

g/l

0.30

Other problems related to primary support group, including family circumstances

234

1.71

2.70

1.2

0.30

0.29

g/l

0.58

194

Superficial injury of shoulder and upper arm

189

1.80

2.69

1.3

1.2

0.30

0.29

g/l

0.17

153

Tooth eruption problems

329

1.59

2.69

1.2

0.29

0.28

g/l

0.23

266

Hypertrophy of breast

357

1.57

2.68

1.3

1.2

0.30

g/l

0.12

285

Renal failure

530

1.43

2.68

1.2

1.3

0.36

0.31

g/l

5.15

432

Peripheral artery disease

387

1.49

2.67

1.2

1.3

0.34

0.31

g/l

2.58

310

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

234

1.71

2.67

1.2

1.3

0.30

g/l

0.05

189

Disorders of breast

150

1006

1.31

2.66

1.3

1.2

0.30

g/l

0.08

123

803

Other diseases of arteries and capillaries

112

2.06

2.66

1.2

0.32

0.29

g/l

1.32

Cardiomyopathy

190

1.79

2.64

1.4

1.2

0.31

0.30

g/l

0.29

153

Sarcoidosis

183

1.81

2.64

1.5

1.2

0.32

0.30

g/l

0.51

148

Iron deficiency

2.40

2.63

1.2

1.1

0.25

0.30

g/l

2.56

Other specified/unspecified bacterial intestinal infections

2.22

2.63

1.4

1.2

0.28

0.30

g/l

0.18

137

923

1.33

2.62

1.2

0.33

0.30

g/l

3.16

111

747

Special screening examination for neoplasms

2.55

2.61

1.1

1.3

0.32

0.31

g/l

—

Transient ischemic attack

102

584

1.39

2.61

1.2

1.3

0.31

g/l

0.05

474

Vulvovaginal ulceration/inflammation in other diseases

155

1.88

2.61

1.1

0.29

g/l

0.13

122

Mental disorders, not otherwise specified

155

1.88

2.61

1.1

1.2

0.32

0.28

g/l

1.59

125

Enterocolitis due to Clostridium difficile

120

2.00

2.60

1.2

0.33

0.30

g/l

0.88

Haemangioma and lymphangioma, any site

141

1.92

2.60

1.3

1.2

0.29

g/l

0.02

116

Striking against or struck by other objects

645

1.41

2.59

1.4

1.2

0.29

0.30

g/l

0.25

518

Medical abortion

184

776

1.28

2.58

1.3

1.2

0.30

g/l

0.58

142

628

Fracture of lower leg, including ankle

135

1002

1.32

2.58

1.2

0.32

0.30

g/l

1.74

105

808

All chronic kidney diseases

119

701

1.35

2.58

1.2

0.34

0.30

g/l

4.05

575

Gonarthrosis,primary

201

958

1.27

2.56

1.2

0.31

g/l

0.06

164

771

Other sleep disorders

149

1.88

2.55

1.3

0.32

0.29

g/l

0.58

120

Diagnoses used for exclusion with ILD

338

1.57

2.55

1.4

1.2

0.32

0.30

g/l

0.82

271

Ethmoidectomy

200

1.75

2.55

1.2

0.29

0.30

g/l

0.50

164

Complications predominantly related to the puerperium

615

1.42

2.55

1.4

1.2

0.29

0.30

g/l

0.41

501

Abnormal weight loss

128

1.96

2.55

1.2

0.29

0.30

g/l

0.21

103

Atherosclerosis, excluding cerebral and coronary sclerosis

351

1.50

2.54

1.3

0.34

0.31

g/l

2.07

280

Suicide or other Intentional self-harm

459

1.48

2.53

1.2

1.3

0.32

0.29

g/l

1.48

370

426

1.48

2.53

1.2

1.3

0.33

0.31

g/l

0.77

347

Skin changes due to chronic exposure to nonionizing radiation

385

1.51

2.53

1.2

1.3

0.32

g/l

0.35

313

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

145

962

1.31

2.52

1.3

1.2

0.30

g/l

0.07

112

767

Hypertensive Heart Disease

139

1.80

2.52

1.2

1.4

0.33

0.30

g/l

1.03

113

Acute alcohol intoxication

387

1.53

2.51

1.3

0.33

0.30

g/l

2.03

318

Actinic keratosis

366

1.52

2.50

1.2

1.3

0.33

0.32

g/l

0.47

295

Iridocyclitis

348

1.55

2.49

1.2

0.30

g/l

0.25

270

ILD, hospital admissions

158

1.84

2.47

1.2

1.3

0.34

0.30

g/l

1.45

123

Retinal vascular occlusion

102

2.06

2.46

1.0

1.2

0.34

0.30

g/l

1.10

Benign neoplasm: Sigmoid colon

225

1.69

2.45

1.2

1.3

0.32

0.31

g/l

0.30

179

Autoimmune hepatitis, wide definition

2.56

2.44

1.2

0.34

0.28

g/l

—

Raynaud syndrome

159

1.83

2.43

1.2

0.28

0.29

g/l

0.40

131

Stroke, excluding SAH

114

609

1.35

2.43

1.1

1.3

0.32

0.31

g/l

1.17

493

Injury of muscle and tendon at shoulder and upper arm level

521

1.44

2.43

1.2

1.3

0.30

0.31

g/l

0.18

426

Other interstitial pulmonary diseases

159

1.83

2.43

1.2

1.3

0.34

0.30

g/l

1.46

125

Interstitial lung disease endpoints

159

1.83

2.43

1.2

1.3

0.34

0.30

g/l

1.45

124

Interstitial lung disease

159

1.83

2.43

1.2

1.3

0.34

0.30

g/l

1.45

124

Pleural effusion

159

1.83

2.43

1.2

1.3

0.35

0.30

g/l

1.84

127

Acute pancreatitis

249

1.65

2.42

1.3

0.32

0.30

g/l

1.00

203

Tobacco use

2.18

2.41

1.5

1.2

0.33

0.29

g/l

1.53

Disorders of parathyroid gland

262

1.62

2.39

1.3

0.33

0.31

g/l

0.94

212

Other and unspecified disorders of autonomic nervous system

6.40

2.39

1.2

1.0

0.29

0.30

g/l

—

Open wound of wrist and hand

113

815

1.34

2.38

1.3

1.2

0.30

g/l

0.10

653

Disorders of tooth development and eruption

202

1.65

2.37

1.3

1.2

0.29

g/l

0.03

156

Statin medication

184

818

1.27

2.37

1.2

1.3

0.31

0.29

g/l

3.67

141

655

Epilepsy

440

1.47

2.37

1.3

1.2

0.31

0.30

g/l

0.27

356

Hordeolum and other deep inflammation of eyelid

2.07

2.37

1.2

1.1

0.31

0.30

g/l

0.49

Other spirochaetal diseases, including avohilmo

608

1.40

2.35

1.4

1.2

0.30

g/l

0.09

488

Retinal vascular disorders

104

2.02

2.35

1.0

1.3

0.34

0.30

g/l

1.12

Retention of urine

362

1.48

2.35

1.3

0.31

0.30

g/l

0.12

292

Other spirochaetal diseases

601

1.40

2.33

1.4

1.2

0.30

g/l

0.07

482

Type 1 diabetes, wide definition

370

1.51

2.32

1.1

1.2

0.32

0.29

g/l

1.91

300

Otalgia

147

1.84

2.32

1.3

1.2

0.30

0.29

g/l

0.06

121

Medical treatment for female infertility

571

1.41

2.32

1.2

0.29

g/l

0.15

459

Pneumonia, organism unspecified

236

1324

1.22

2.29

1.4

1.2

0.31

0.30

g/l

1.27

191

1066

AV-block

144

1.78

2.28

1.3

1.2

0.30

0.31

g/l

0.06

113

Weight loss

141

1.85

2.27

1.2

0.29

g/l

0.08

113

Disorders of choroid and retina

177

984

1.26

2.27

1.2

0.31

g/l

0.40

145

796

Haemangioma, any site

134

1.87

2.26

1.1

1.2

0.30

0.29

g/l

0.35

109

Sudden idiopathic hearing loss

134

1.87

2.26

1.4

1.2

0.32

0.30

g/l

0.65

109

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

325

1.54

2.26

1.2

1.3

0.30

0.29

g/l

0.48

268

Lichen simplex chronicus and prurigo

2.28

2.24

1.3

1.2

0.37

0.29

g/l

—

Myocardial infarction, strict

407

1.41

2.24

1.1

1.3

0.33

0.31

g/l

1.37

331

Acute and subacute iridocyclitis

294

1.57

2.23

1.2

0.30

g/l

0.05

232

Periapical abscess

116

880

1.32

2.23

1.2

0.32

0.30

g/l

0.97

718

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

262

1447

1.21

2.22

1.4

1.2

0.31

0.30

g/l

1.63

211

1156

Embedded teeth, including avohilmo

194

1.71

2.22

1.2

1.3

0.29

0.28

g/l

0.42

155

Assault by bodily force

135

1.86

2.22

1.5

1.2

0.31

0.29

g/l

0.59

112

Pacemaker

370

1.48

2.22

1.3

0.31

g/l

0.09

300

Superficial injuries involving multiple body regions

2.70

2.21

1.5

1.1

0.35

0.29

g/l

—

Other diseases of stomach and duodenum

2.20

2.21

1.4

1.2

0.29

0.30

g/l

0.08

Chalazion

165

1.76

2.18

1.5

1.3

0.29

0.30

g/l

0.21

134

Oxicams

142

1.64

2.18

1.3

1.2

0.31

g/l

0.03

116

Acute alcohol intoxication, ICD10

320

1.53

2.18

1.3

0.31

0.29

g/l

0.89

258

Other disorders of the genitourinary system

173

1.74

2.16

1.1

1.2

0.31

g/l

0.04

139

Diseases of male genital organs

331

1.39

2.15

1.2

1.3

0.30

0.31

g/l

0.85

264

Coeliac disease

196

1.69

2.15

1.3

0.30

g/l

0.07

161

Other fall from one level to another

394

1.47

2.14

1.3

0.31

0.29

g/l

1.06

318

Other CVD

219

1.65

2.14

1.1

1.2

0.33

0.31

g/l

1.16

174

Dysplasia of cervi uteri

332

1.44

2.14

1.1

1.2

0.29

0.30

g/l

0.86

264

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

106

1.95

2.13

1.4

1.2

0.27

0.29

g/l

0.40

Personal history of other diseases and conditions

234

1.62

2.12

1.2

0.33

0.28

g/l

2.07

199

Ulcer of oesophagus

2.37

2.12

1.5

1.2

0.28

0.30

g/l

—

Bacterial pneumonia, not elsewhere classified

521

1.38

2.12

1.4

1.2

0.33

0.30

g/l

2.21

425

Major coronary heart disease event excluding revascularizations

109

541

1.33

2.11

1.3

0.33

0.31

g/l

1.80

442

Lyme disease

596

1.38

2.11

1.4

1.2

0.30

g/l

0.10

478

Lyme disease, including avohilmo

596

1.38

2.11

1.4

1.2

0.30

g/l

0.10

478

Pregnancy hypertension

132

918

1.29

2.10

1.3

1.2

0.30

g/l

0.07

102

731

Abnormal serum enzyme levels

374

1.47

2.09

1.3

0.33

0.30

g/l

1.60

305

Arthropod-borne viral fevers and viral haemorrhagic fevers

131

1.84

2.07

1.3

1.2

0.30

0.29

g/l

0.14

105

Other disorders of ear

227

1209

1.21

2.07

1.2

0.30

0.31

g/l

0.14

172

982

Coagulation defects, purpura and other haemorrhagic conditions

316

1.52

2.07

1.3

1.2

0.31

0.30

g/l

0.48

252

Spirochaetal infections, other/unspecified, including avohilmo

598

1.37

2.07

1.4

1.2

0.30

g/l

0.08

480

Other retinal disorders

128

753

1.29

2.06

1.3

1.2

0.32

0.31

g/l

0.64

105

607

Other benign neoplasms of skin

607

1.37

2.06

1.3

1.2

0.31

0.30

g/l

0.15

492

Contraceptive management

113

601

1.32

2.05

1.3

1.2

0.29

0.31

g/l

1.74

483

Hallux valgus (acquired)

329

1.44

2.05

1.1

1.2

0.30

0.31

g/l

0.62

265

Dislocation, sprain and strain of joints and ligaments of head

2.18

2.04

1.4

1.2

0.33

0.29

g/l

—

Superficial injury of ankle and foot

238

1.60

2.03

1.5

1.2

0.33

0.29

g/l

3.35

191

Abnormal results of function studies

132

1.82

2.03

1.4

1.2

0.32

0.30

g/l

0.88

105

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

425

1.44

2.01

1.3

1.2

0.29

g/l

0.04

340

141

968

1.27

2.00

1.2

0.33

0.30

g/l

3.18

114

786

All pneumoniae

268

1464

1.19

1.99

1.4

1.2

0.31

0.30

g/l

1.59

216

1168

Acute tubulo-interstitial nephritis

154

1039

1.25

1.97

1.3

1.2

0.32

0.30

g/l

2.24

119

848

Haemorrhage in early pregnancy

636

1.35

1.97

1.2

0.30

g/l

0.13

507

Abrasion of teeth

699

1.33

1.95

1.4

1.2

0.29

0.30

g/l

1.30

564

Care involving dialysis

1.94

1.95

1.1

1.2

0.36

0.30

g/l

1.99

Autonomic disorders

2.58

1.94

1.3

1.2

0.30

0.28

g/l

—

Other and unspecified injuries of lower leg

127

1.82

1.93

1.3

1.2

0.31

0.28

g/l

1.16

109

Fracture of shoulder and upper arm

554

1.37

1.93

1.4

1.3

0.31

0.30

g/l

0.24

453

Atrophic disorders of skin

250

1.56

1.91

1.2

0.32

0.30

g/l

0.86

203

Seborrhoeic dermatitis

113

1.86

1.91

1.6

1.2

0.31

0.30

g/l

0.45

Alcohol use disorder, Swedish definition

120

851

1.28

1.90

1.2

0.34

0.30

g/l

3.78

684

Sub-endpoint used in defining T1D endpoints

456

1.40

1.89

1.0

1.3

0.33

0.29

g/l

2.27

369

Other coagulation defects

128

1.80

1.89

1.1

1.2

0.31

0.29

g/l

0.84

102

Redundant prepuce, phimosis and paraphimosis

239

1.57

1.89

1.2

1.3

0.29

0.30

g/l

0.71

193

Excessive attrition of teeth

168

1354

1.23

1.87

1.3

1.2

0.30

g/l

0.03

138

1084

Coronary atherosclerosis

120

588

1.29

1.87

1.4

1.3

0.32

0.31

g/l

0.62

480

Bacterial pneumoniae

564

1.34

1.86

1.4

1.2

0.33

0.30

g/l

2.35

461

Other pleural conditions

107

1.87

1.86

1.2

0.33

0.30

g/l

0.97

Pneumonias (Asthma/COPD co-morbidities)

265

1465

1.18

1.85

1.4

1.2

0.31

0.30

g/l

1.57

213

1169

Acute gastritis

1.98

1.84

1.4

1.2

0.32

0.31

g/l

0.20

Colonic or urogenital fistula

433

1.41

1.84

1.2

1.3

0.32

0.30

g/l

1.13

344

Urolithiasis

459

1.40

1.82

1.5

1.2

0.29

0.30

g/l

0.39

369

Embedded and impacted teeth

544

1.33

1.82

1.3

1.2

0.30

0.29

g/l

0.53

436

Scabies, including avohilmo

310

1.49

1.82

1.4

1.2

0.29

g/l

0.09

253

Other obstetric conditions, not elsewhere classified

125

619

1.28

1.82

1.2

0.29

g/l

0.24

496

Keratitis

630

1.33

1.81

1.3

1.2

0.30

g/l

0.04

500

Cervical polyps

160

1.69

1.81

1.1

1.2

0.30

0.31

g/l

0.26

127

Mucosal proctocolitis

199

1.61

1.79

1.2

0.30

0.29

g/l

0.26

162

Disorders of lens

142

703

1.25

1.79

1.2

1.3

0.32

0.31

g/l

1.28

112

582

Alcohol abuse, main dg, excluding more controls

223

1.57

1.78

1.5

1.3

0.31

0.29

g/l

0.82

185

Follicular cysts of skin and subcutaneous tissue

271

1.52

1.78

1.1

1.3

0.32

0.30

g/l

0.52

220

Heart failure,strict

462

1.33

1.77

1.3

0.34

0.30

g/l

3.40

378

Bacterial pneumonia (organism specified)

611

1.32

1.77

1.4

1.3

0.33

0.30

g/l

2.23

492

Complications of the puerperium, not elsewhere classified

1.90

1.75

1.2

1.1

0.29

g/l

0.05

Other noninflammatory disorders of uterus, except cervix

206

1.49

1.75

1.2

0.31

0.32

g/l

0.13

164

Ménière disease

117

1.80

1.74

1.2

0.33

0.30

g/l

0.87

Coxarthrosis [arthrosis of hip](FG)

523

1.30

1.73

1.2

0.31

g/l

0.38

436

Renal tubulo-interstitial diseases

216

1328

1.19

1.72

1.3

1.2

0.32

0.30

g/l

3.68

167

1080

Female genital prolapse

268

1.39

1.72

1.3

1.2

0.30

0.31

g/l

0.26

213

Routine general health check-up of defined subpopulation

2.93

1.72

1.0

1.1

0.29

g/l

—

Toxic effects of substances chiefly nonmedicinal as to source

179

1.62

1.69

1.3

1.2

0.29

g/l

0.04

148

Adalimumab

187

1.61

1.68

1.5

1.2

0.31

0.29

g/l

0.59

154

Acute pancreatitis (for exclusion)

275

1.49

1.68

1.3

0.32

0.30

g/l

1.03

223

Bipolar affective disorders

341

1.44

1.67

1.1

1.2

0.33

0.29

g/l

2.25

280

Other cataract

485

1.32

1.67

1.2

1.3

0.32

0.31

g/l

0.70

400

Assault

235

1.53

1.67

1.4

1.2

0.31

0.29

g/l

0.52

190

Primary gonarthrosis, bilateral

643

1.29

1.67

1.2

1.3

0.31

g/l

0.24

529

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

2.45

1.64

1.3

1.1

0.30

0.31

g/l

—

Single delivery by forceps and vacuum extractor

280

0.64

1.64

1.1

1.2

0.29

0.30

g/l

0.55

222

Viral infections of the central nervous system, including avohilmo

127

1.74

1.64

1.9

1.2

0.27

0.29

g/l

0.33

106

Pregnancy with abortive outcome

182

784

1.21

1.63

1.3

1.2

0.29

0.30

g/l

1.34

143

635

Cardiomyopathies, Primary/intrinsic

127

1.74

1.63

1.5

1.2

0.29

0.30

g/l

0.28

100

Other abnormal uterine and vaginal bleeding

262

1.43

1.63

1.3

1.2

0.29

0.30

g/l

0.87

210

Endometriosis diagnosis and infertility diagnosis occurring together

253

1.51

1.62

1.1

1.2

0.28

0.29

g/l

0.41

202

Postmenopausal bleeding

202

1.43

1.62

1.4

1.2

0.32

g/l

0.11

160

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

121

606

1.26

1.62

1.2

0.29

g/l

0.26

485

Other abnormal products of conception

110

568

1.27

1.61

1.3

1.2

0.29

0.30

g/l

0.88

463

Anterior Iridocyclitis

319

1.44

1.61

1.2

0.30

g/l

0.04

255

Later onset COPD, excluding more controls

137

1.61

1.60

1.2

0.34

0.31

g/l

1.18

108

Thyrotoxicosis, other and/or unspecified

336

1.43

1.60

1.2

0.31

0.30

g/l

0.25

271

Hypotension

174

1.61

1.60

1.1

1.3

0.33

0.31

g/l

1.13

137

COPD (mode)

248

1.45

1.58

1.2

0.33

0.30

g/l

1.56

196

Melanocytic naevi

612

1.31

1.55

1.2

0.30

g/l

0.00

485

Calculus of kidney and ureter

431

1.37

1.55

1.5

1.2

0.29

0.30

g/l

0.39

349

Open wound of ankle and foot

145

1.66

1.53

1.2

0.30

0.29

g/l

0.21

117

Persons encountering health services in circumstances related to reproduction

140

765

1.23

1.53

1.3

1.2

0.29

0.31

g/l

1.28

114

618

Bacterial, viral and other infectious agents, including avohilmo

153

1.64

1.53

1.0

1.3

0.31

0.29

g/l

0.46

126

Bacterial, viral and other infectious agents

138

1.67

1.51

1.0

1.3

0.30

0.29

g/l

0.23

113

Presence of other functional implants

112

611

1.26

1.51

1.2

0.32

0.30

g/l

1.51

506

Other specified and unspecified disorders of eye and adnexa

2.17

1.50

1.1

1.2

0.31

0.29

g/l

0.42

Unspecified lump in breast

275

1.46

1.48

1.2

0.32

0.31

g/l

0.50

214

Any dementia

290

0.64

1.48

1.1

1.3

0.33

0.31

g/l

0.32

230

Other disorders of veins

721

1.27

1.46

1.2

0.31

g/l

0.12

579

Glomerulonephritis

132

1.67

1.45

1.3

1.2

0.36

0.30

g/l

3.01

104

Alzheimer disease

228

0.60

1.45

1.1

1.3

0.33

0.32

g/l

0.42

178

Gestational [pregnancy-induced] hypertension

636

1.29

1.44

1.3

1.2

0.30

0.29

g/l

0.13

516

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

3.14

1.44

1.2

1.1

0.27

0.28

g/l

—

Extracorporeal dialysis

1.92

1.43

1.1

1.2

0.36

0.30

g/l

—

Other hearing loss

341

1.39

1.43

1.3

1.2

0.32

0.31

g/l

0.31

279

Pterygium

2.74

1.43

1.0

1.2

0.30

0.27

g/l

—

Unspecified acute lower respiratory infection

228

1.49

1.43

1.2

0.31

0.30

g/l

0.33

182

Benign neoplasm: Liver

2.32

1.43

1.0

1.2

0.32

0.29

g/l

—

Other diseases of blood and blood-forming organs, wide

336

1.40

1.43

1.4

1.2

0.32

0.30

g/l

0.60

274

Pediculosis, acariasis and other infestations, including avohilmo

353

1.39

1.42

1.4

1.2

0.30

0.29

g/l

0.14

290

Seropositive rheumatoid arthritis, wide

387

1.37

1.42

1.1

1.2

0.33

0.31

g/l

1.24

304

Ankylosing spondylitis, ICD10

133

1.66

1.42

1.3

1.2

0.31

0.29

g/l

0.64

107

Cardiomyopathy (excluding other)

133

1.66

1.42

1.5

1.2

0.29

0.30

g/l

0.24

105

Hyperparathyroidism

226

1.49

1.41

1.2

0.33

0.31

g/l

0.61

184

Hyperplasia of prostate

234

1.37

1.41

1.2

1.3

0.30

0.32

g/l

1.04

186

Other inflammatory liver diseases

1.82

1.41

1.2

0.34

0.30

g/l

—

Disorders of eyelid in diseases classified elsewhere

2.26

1.40

1.2

1.1

0.32

0.30

g/l

—

Thyrotoxicosis

440

1.34

1.39

1.2

0.31

0.30

g/l

0.21

353

Impacted teeth

421

1.33

1.39

1.3

1.2

0.29

g/l

0.32

338

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

449

1.34

1.39

1.3

1.2

0.28

0.29

g/l

0.65

367

Propionic acid derivatives

192

1.39

1.38

1.2

0.27

0.30

g/l

2.83

156

Other secondary gonarthrosis

2.01

1.38

1.2

1.3

0.28

0.30

g/l

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

190

1.53

1.37

1.3

1.1

0.31

0.29

g/l

0.77

156

Diseases of the myoneural junction and muscle

158

1.58

1.37

1.2

1.3

0.31

0.30

g/l

0.15

126

Chronic tubulo-interstitial nephritis

2.20

1.37

1.4

1.1

0.35

0.29

g/l

—

Amyloidosis

2.95

1.36

1.2

0.33

0.27

g/l

—

Other maltreatment syndromes

0.00

1.34

0.0

1.2

—

0.28

—

Astigmatism

1.75

1.34

1.5

1.1

0.29

g/l

—

COPD, hospital admissions 1, only main diagnosis

329

1.36

1.32

1.3

0.33

0.31

g/l

1.18

264

Inguinal or femoral hernia, bilateral

113

1.68

1.31

1.2

1.3

0.33

0.30

g/l

1.26

Diabetes mellitus in pregnancy

116

601

1.23

1.31

1.1

1.2

0.30

0.29

g/l

0.99

474

Injury of eye and orbit

217

1.48

1.30

1.4

1.2

0.28

0.29

g/l

0.21

177

Fitting and adjustment of other devices

422

1.32

1.30

1.3

0.31

g/l

0.29

343

Juvenile arthritis (FINNGEN)

1.85

1.29

1.1

1.2

0.30

0.28

g/l

0.46

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

377

1.35

1.29

1.1

1.2

0.33

0.31

g/l

1.48

297

Other mental disorders due to brain damage and dysfunction and to physical disease

129

1.63

1.29

1.1

1.3

0.31

0.30

g/l

0.05

102

Unspecified haematuria

490

1.28

1.29

1.3

0.30

0.31

g/l

0.60

396

Drug-induced osteoporosis with pathological fracture

2.79

1.28

1.6

1.3

0.38

0.27

g/l

—

Sequelae of injuries of upper limb

145

1.59

1.28

1.2

0.29

g/l

0.05

118

Status post-ami

195

1.44

1.28

1.1

1.4

0.32

0.31

g/l

0.39

155

Disorders of psychological development

217

1.45

1.27

1.0

1.3

0.29

0.28

g/l

0.34

174

Alcohol abuse, main dg

244

1.44

1.25

1.5

1.3

0.31

0.29

g/l

0.86

200

ILD, hospital admission 2, with pulmonary infections

1.74

1.24

1.1

1.2

0.36

0.29

g/l

1.76

Other and unspecified mononeuropathies of lower limb

2.41

1.24

1.5

1.1

0.28

g/l

—

Endometriosis ASRM stages 3,4

467

1.31

1.24

1.1

1.2

0.30

g/l

0.11

375

245

1.40

1.24

1.3

0.31

0.32

g/l

0.29

187

Benign neoplasm: Liver/bile ducts

2.01

1.23

1.0

1.2

0.32

0.29

g/l

—

Other predominantly sexually transmitted diseases, not elsewhere classified

355

1.35

1.23

1.3

1.2

0.27

0.29

g/l

0.82

288

Other/unspecified seropositive rheumatoid arthritis

381

1.34

1.22

1.1

1.2

0.33

0.31

g/l

1.48

300

Pre-eclampsia or eclampsia

477

1.30

1.22

1.3

1.2

0.30

g/l

0.15

389

Procedures for purposes other than remedying health state

2.17

1.21

1.5

1.1

0.32

0.29

g/l

—

Preterm labour and delivery

540

1.28

1.19

1.4

1.2

0.29

0.31

g/l

0.83

441

Abnormal findings on diagnostic imaging of other body structures

205

1.47

1.19

1.3

1.2

0.31

0.30

g/l

0.41

167

Thyrotoxicosis with diffuse goitre

239

1.42

1.17

1.2

0.30

g/l

0.29

194

Use of levodopa decarboxylase inhibitor

125

1.60

1.17

1.3

0.34

0.31

g/l

0.39

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

161

1068

1.17

1.16

1.2

0.30

g/l

0.33

125

847

Presence of other devices

294

1.37

1.16

1.3

0.31

0.30

g/l

0.33

238

Any dementia, excluding more controls

271

0.68

1.15

1.1

1.3

0.32

0.31

g/l

0.56

218

Pedal cyclist injured in transport accident

394

1.32

1.15

1.4

1.3

0.32

0.29

g/l

1.53

314

Pericarditis

2.06

1.15

1.3

1.2

0.32

0.28

g/l

—

conjunctival degenerations and deposits

2.51

1.15

1.2

1.3

0.31

0.27

g/l

—

Inguinal hernia, bilateral

110

1.64

1.15

1.2

1.3

0.33

0.30

g/l

1.24

Osteonecrosis

1.81

1.15

1.2

0.32

0.30

g/l

—

Adenocarcinoma and ductal carcinoma of pancreas

0.00

1.14

0.0

1.1

—

0.30

—

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

224

0.62

1.13

1.8

1.2

0.27

0.32

g/l

0.67

181

Ulcerative proctitis

1.69

1.13

1.1

0.33

0.29

g/l

0.83

Other juvenile arthritis

1.85

1.13

1.1

1.2

0.30

0.28

g/l

0.62

Degeneration of macula and posterior pole

453

1.26

1.13

1.3

0.31

g/l

0.31

360

Single delivery by caesarean section

313

1.28

1.12

1.1

1.2

0.29

0.30

g/l

0.39

251

Parkinson's disease, strict definition, excluding more controls

103

1.63

1.12

1.3

1.4

0.35

0.32

g/l

0.27

Alcohol dependence

387

1.32

1.12

1.1

1.2

0.34

0.30

g/l

2.70

315

Abscess of Bartholin gland

1.91

1.12

1.8

1.1

0.27

0.29

g/l

0.79

Perineal laceration during delivery

400

0.73

1.12

1.3

1.2

0.29

g/l

0.07

319

Acne

232

1.42

1.12

1.5

1.2

0.28

g/l

0.26

190

Parkinson's disease, excluding more controls

109

1.60

1.11

1.3

1.4

0.35

0.32

g/l

0.32

Nontraumatic intracranial haemmorrhage

200

1.45

1.11

1.4

1.2

0.30

0.31

g/l

0.39

159

Viral pneumonia (known virus, not influenza)

2.27

1.10

1.9

1.1

0.30

g/l

—

Insulin, fast-acting (human)

234

1.41

1.10

1.0

1.2

0.31

0.28

g/l

0.81

187

Glaucoma suspect

529

1.27

1.10

1.3

1.2

0.31

g/l

0.19

425

Adhesive capsulitis of shoulder

209

1.44

1.10

1.4

1.2

0.33

0.30

g/l

0.91

159

Excessive earwax

132

1013

1.18

1.09

1.3

1.2

0.31

0.30

g/l

0.62

106

824

Other disorders of central nervous system

2.39

1.09

1.2

1.1

0.31

0.26

g/l

—

Other and unspecified hydrocephalus

2.39

1.09

1.0

1.2

0.32

0.31

g/l

—

L02BG Aromatase inhibitors

454

1.28

1.08

1.3

1.2

0.33

0.31

g/l

0.88

372

Other diseases of blood and blood-forming organs

1.69

1.07

1.3

1.2

0.34

0.30

g/l

—

Postmenopausal atrophic vaginitis

224

1.31

1.07

1.2

0.30

0.32

g/l

0.76

177

Presence of cardiac and vascular implants and grafts

402

1.26

1.07

1.3

0.33

0.31

g/l

1.25

331

Injury of other and unspecified intrathoracic organs

1.76

1.06

1.0

1.2

0.32

0.29

g/l

—

Obstructed labour due to malposition and malpresentation of fetus

550

1.25

1.06

1.2

0.30

g/l

0.11

434

Other disorders of amniotic fluid and membranes

369

1.31

1.06

1.3

1.2

0.30

0.29

g/l

0.29

302

Other sexually transmitted chlamydial diseases

129

1.55

1.05

1.3

1.2

0.28

g/l

0.25

101

Cholecystitis

170

1.47

1.04

1.3

0.29

0.30

g/l

0.18

135

Malignant neoplasm of breast

591

0.81

1.04

1.2

0.32

0.31

g/l

0.29

471

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

237

1.39

1.04

1.2

0.32

0.31

g/l

0.25

195

Persons with potential health hazards related to communicable diseases

105

870

1.20

1.03

1.2

0.31

0.29

g/l

1.13

715

Combinations of oral blood glucose lowering drugs

358

1.31

1.03

1.2

0.33

0.31

g/l

0.96

290

Malignant neoplasm of head and neck, including Hilmo

1.63

1.03

1.4

1.3

0.32

0.31

g/l

0.13

Malignant neoplasm of breast, HER2-negative

590

0.81

1.02

1.2

0.32

0.31

g/l

0.29

470

Strabismus

490

1.26

1.01

1.2

0.33

0.29

g/l

1.48

400

Hypocalcemia

2.01

1.00

1.0

1.3

0.35

0.27

g/l

—

Dermatophytosis, including avohilmo

156

1325

1.15

1.00

1.2

0.31

0.30

g/l

0.28

128

1064

Retinal detachments and breaks

484

1.26

0.99

1.2

1.3

0.31

g/l

0.10

385

Malignant neoplasm of breast, including Hilmo

604

0.82

0.98

1.2

0.31

g/l

0.21

481

Malignant neoplasm of breast, HER2-negative, including Hilmo

604

0.82

0.98

1.2

0.31

g/l

0.21

481

Fracture of skull and facial bones

326

1.32

0.98

1.4

1.3

0.31

0.29

g/l

0.39

267

Eosinophilia

2.18

0.98

1.0

1.2

0.32

0.28

g/l

—

Dementia, including avohilmo

369

0.76

0.98

1.1

1.3

0.33

0.31

g/l

0.47

295

Anti-inflammatory and antirheumatic products, non-steroids

192

1.31

0.98

1.2

0.28

0.30

g/l

1.41

156

Pemphigoid

0.00

0.98

0.0

1.2

—

0.28

—

Adenocarcinoma of pancreas

0.00

0.97

0.0

1.1

—

0.30

—

Acne vulgaris

181

1.44

0.97

1.2

1.3

0.28

g/l

0.01

152

Infliximab

1.95

0.97

1.0

1.2

0.29

g/l

—

Graves ophthalmopathy, strict

0.00

0.96

0.0

1.1

—

0.28

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

108

1.58

0.96

1.3

1.2

0.29

g/l

0.11

Fracture of femur

263

1.34

0.96

1.1

1.3

0.33

0.31

g/l

0.81

211

HSIL lesion of the cervix uteri, vagina or vulva

507

1.24

0.93

1.2

0.29

0.30

g/l

0.49

416

Non-ischemic cardiomyopathy

295

1.29

0.92

1.2

1.3

0.33

0.31

g/l

1.23

241

Exposure to other and unspecified animate mechanical forces

1.82

0.92

1.1

0.31

0.29

g/l

—

Myopia

269

1.34

0.92

1.4

1.3

0.32

0.29

g/l

1.51

222

Heterophoria

142

1.48

0.92

1.2

0.33

0.28

g/l

—

116

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

295

1.32

0.91

1.1

1.3

0.30

0.29

g/l

0.02

241

Gestational diabetes (for exclusion)

126

744

1.17

0.90

1.1

1.2

0.31

0.29

g/l

1.46

588

Pre-eclampsia

446

1.26

0.90

1.2

0.30

g/l

0.00

362

Varicose veins

121

783

1.17

0.90

1.3

1.2

0.30

0.31

g/l

0.33

631

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

2.07

0.89

3.3

1.1

0.23

0.31

g/l

—

Chronic lymphocytic leukaemia

2.07

0.89

3.3

1.1

0.23

0.31

g/l

—

Chronic lymphocytic leukaemia, helper endpoint

2.07

0.89

3.3

1.1

0.23

0.31

g/l

—

Diabetic neuropathy

151

1.45

0.88

1.0

1.3

0.33

0.31

g/l

0.45

123

Dementia

340

0.76

0.88

1.1

1.3

0.32

0.31

g/l

0.40

274

Diabetic retinopathy, excluding more controls

258

1.26

0.88

1.2

1.3

0.33

0.32

g/l

0.72

208

Benign neoplasm: Choroid

1.65

0.88

1.2

0.30

0.29

g/l

—

Fibrosis and cirrhosis of liver

1.61

0.87

1.4

1.2

0.30

g/l

—

Benign neoplasm: Skin of eyelid, including canthus

203

1.38

0.87

1.5

1.2

0.29

0.31

g/l

0.54

161

Artificial joint operation, meniscal resection

188

1065

1.13

0.86

1.3

1.2

0.32

0.31

g/l

0.97

146

859

Seborrhoeic keratosis

325

1.29

0.86

1.3

1.2

0.34

0.31

g/l

1.84

259

Other medical care

653

1.18

0.83

1.2

0.31

0.30

g/l

0.16

532

Gingival hyperplasia

1.74

0.82

1.0

1.2

0.37

0.29

g/l

—

Other and unspecified glaucoma

1.69

0.82

1.1

1.2

0.35

0.31

g/l

0.78

Benign neoplasm: Skin of other and unspecified parts of face

146

1.44

0.82

1.2

0.32

0.30

g/l

0.66

120

HSIL lesion of the cervix uteri

480

1.23

0.81

1.2

0.28

0.29

g/l

0.49

395

Other menopausal disorders

270

1.24

0.81

1.2

0.28

0.31

g/l

2.51

217

Heart failure, strict

528

1.18

0.81

1.3

0.34

0.31

g/l

2.88

430

Retained placenta and membranes, without haemorrhage

232

1.34

0.81

1.3

1.2

0.30

g/l

0.45

192

Unspecified mental disorder

782

1.18

0.81

1.1

1.3

0.33

0.30

g/l

3.29

628

Use of pramipexole

302

1.29

0.80

1.3

1.2

0.30

0.31

g/l

0.21

237

Benign neoplasm: Rectum

215

1.35

0.80

1.1

1.3

0.35

0.31

g/l

2.01

171

Eustachian salpingitis and obstruction

164

1.40

0.79

1.3

1.2

0.32

0.29

g/l

0.89

130

Malignant neoplasm of respiratory system and intrathoracic organs

196

0.68

0.79

1.6

1.2

0.27

0.32

g/l

0.66

158

Type 1 diabetes, strict (exclude DM2)

172

1.39

0.79

1.1

1.2

0.32

0.28

g/l

1.70

137

Helminthiases

0.00

0.79

0.0

1.1

—

0.30

—

Other aneurysm

1.67

0.78

1.1

1.3

0.33

0.28

g/l

—

Diseases of peritoneum

131

1.45

0.78

1.4

1.3

0.34

0.30

g/l

0.81

106

Disorders of calcium metabolism

1.59

0.78

1.0

1.3

0.35

0.29

g/l

2.23

Erosion of teeth , including avohilmo

565

1.20

0.78

1.2

0.31

0.29

g/l

0.70

456

Malignant neoplasm of head and neck

1.59

0.77

1.5

1.2

0.30

0.31

g/l

—

Schizophrenia or delusion, excluding more controls

495

1.22

0.77

1.1

1.3

0.32

0.29

g/l

2.12

405

Parkinson's disease, including avohilmo

148

1.42

0.77

1.3

0.35

0.30

g/l

0.76

115

Type 1 diabetes, definitions combined

173

1.38

0.77

1.1

1.2

0.32

0.28

g/l

1.73

138

Graves disease, strict definition

191

1.36

0.76

1.1

1.2

0.31

0.29

g/l

0.49

153

Benign neoplasm of eye and adnexa

140

1.43

0.76

1.2

0.29

0.30

g/l

0.13

113

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

157

1.40

0.76

1.3

1.2

0.32

0.30

g/l

1.23

129

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

279

1.29

0.75

1.1

1.3

0.30

0.29

g/l

0.13

230

Other melanin hyperpigmentation

2.09

0.74

1.6

1.2

0.36

0.29

g/l

—

All-cause Heart Failure

521

1.17

0.74

1.2

1.3

0.34

0.31

g/l

2.87

423

Congenital malformations of eye, ear, face and neck

116

1.47

0.74

1.5

1.2

0.27

0.29

g/l

0.24

Focal epilepsy

324

1.27

0.74

1.3

1.2

0.31

0.30

g/l

0.27

259

Malignant neoplasm of prostate

193

0.74

0.73

1.3

0.33

0.31

g/l

0.68

158

Testicular hypofunction

1.85

0.73

2.0

1.3

0.32

0.29

g/l

—

Endocarditis

1.85

0.73

1.1

1.2

0.36

0.29

g/l

—

Hypermetropia

108

1.48

0.73

1.2

0.32

0.29

g/l

—

Congenital malformations of the circulatory system

247

1.30

0.72

1.2

0.30

0.29

g/l

0.17

202

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

317

1.26

0.71

1.1

1.2

0.31

0.29

g/l

0.55

254

Supervision of high-risk pregnancy

319

1.21

0.71

1.2

0.29

0.30

g/l

0.61

261

Other specified disorders of kidney and ureter

1.75

0.71

1.0

1.1

0.32

0.29

g/l

—

Retinal haemorrhage

1.93

0.70

1.0

1.2

0.36

0.29

g/l

—

Purpura and other haemorrhagic conditions

203

1.33

0.70

1.4

1.3

0.30

g/l

0.09

162

Pregnancy, childbirth and the puerperium

296

1.20

0.70

1.2

0.29

0.31

g/l

1.81

242

Benign neoplasm: Rectum, anus and anal canal

247

1.30

0.70

1.3

1.2

0.33

0.31

g/l

0.78

199

Other obstructed labour

152

1.38

0.69

1.3

1.2

0.31

0.30

g/l

0.20

123

Injuries to the elbow and forearm

169

1302

1.11

0.68

1.2

0.31

0.30

g/l

0.20

140

1050

Dilated cardiomyopathy

127

1.42

0.67

1.3

0.28

0.30

g/l

0.43

Parkinson's disease, strict definition

127

1.42

0.67

1.3

0.35

0.30

g/l

0.49

Postpartum care and examination

233

1.24

0.67

1.2

0.30

g/l

0.07

190

Testicular dysfunction

1.63

0.67

2.0

1.3

0.32

0.29

g/l

—

Other degenerative diseases of the nervous system

252

1.24

0.66

1.1

1.3

0.34

0.30

g/l

2.34

198

Malignant neoplasm of breast, HER-negative

294

0.75

0.66

1.2

0.30

0.31

g/l

0.31

242

Malignant neoplasm of other connective and soft tissue

1.79

0.66

1.4

1.1

0.32

0.30

g/l

—

Chronic ulcer of skin, not elsewhere classified

1.54

0.65

1.3

0.38

0.29

g/l

—

Scar conditions and fibrosis of skin

1.58

0.65

1.2

1.1

0.32

0.29

g/l

—

Primary hyperparathyroidism

137

1.39

0.64

1.3

1.2

0.35

0.30

g/l

1.46

113

Dependent personality disorder

1.73

0.64

1.4

1.1

0.28

g/l

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

143

941

1.12

0.64

1.3

1.2

0.30

g/l

0.44

111

746

Pre-eclampsia or poor fetal growth

771

1.15

0.63

1.3

1.2

0.31

0.30

g/l

0.46

627

Malignant neoplasm of skin

547

0.85

0.63

1.3

1.2

0.31

g/l

0.04

452

Contact with and exposure to communicable diseases

735

1.15

0.62

1.2

0.30

0.29

g/l

0.52

609

Foreign body in ear

1.67

0.61

2.0

1.1

0.31

0.30

g/l

—

Secondary malignant neoplasm of other and unspecified sites

0.00

0.60

0.0

1.2

—

0.30

—

Brain glioblastoma and astrocytoma

0.00

0.60

0.0

1.1

—

0.28

—

Single spontaneous delivery

465

0.86

0.59

1.2

0.30

0.31

g/l

0.50

372

Toxic effect of other and unspecified substances

0.00

0.58

0.0

1.1

—

0.31

—

Normal-pressure hydrocephalus

1.72

0.57

1.0

1.2

0.28

0.30

g/l

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

282

1.24

0.57

1.4

1.2

0.30

g/l

0.11

228

False labour

541

1.14

0.57

1.3

1.2

0.28

0.30

g/l

1.76

432

Maternal care for other known or suspected fetal problems

471

1.15

0.56

1.3

1.2

0.30

0.29

g/l

0.10

379

Maternal care for known or suspected abnormality of pelvic organs

489

1.15

0.56

1.2

0.30

g/l

0.14

391

Premature rupture of membranes

430

0.84

0.55

1.5

1.2

0.29

g/l

0.08

349

Maternal care for known or suspected malpresentation of fetus

404

1.17

0.55

1.2

0.30

0.29

g/l

0.56

326

Family history of malignant neoplasm

212

1.27

0.55

1.0

1.2

0.32

0.29

g/l

1.56

178

Effects of foreign body entering through natural orifice

403

1.19

0.54

1.4

1.3

0.28

0.30

g/l

0.92

328

Disorders of speech understanding and production

1.53

0.54

1.0

1.2

0.30

0.28

g/l

—

Carrier of infectious disease

1.58

0.54

1.0

1.1

0.32

0.29

g/l

—

Primary angle-closure glaucoma

1.58

0.54

1.0

1.2

0.26

0.30

g/l

—

Parkinson's disease

142

1.34

0.54

1.3

0.35

0.30

g/l

0.61

111

Right bundle-branch block

1.54

0.53

1.2

0.32

0.29

g/l

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

130

687

1.11

0.52

1.2

0.29

0.30

g/l

1.87

105

555

Transient global amnesia

0.62

0.52

1.0

1.3

0.28

0.30

g/l

—

Multiple myeloma and malignant plasma cell neoplasms

1.50

0.51

1.3

0.32

0.29

g/l

—

Any event in cancer register

196

1240

0.92

0.51

1.3

1.2

0.30

g/l

0.09

154

993

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

179

1.29

0.51

1.2

1.3

0.31

0.30

g/l

0.05

142

Labour and delivery complicated by fetal stress [distress]

466

0.86

0.51

1.2

0.29

g/l

0.34

366

Other sexually transmitted chlamydial diseases, including avohilmo

224

1.25

0.50

1.2

0.28

g/l

0.30

174

Malignant neoplasm of prostate, including Hilmo

193

0.79

0.50

1.2

1.3

0.33

0.31

g/l

0.91

158

Artificial opening status

1.39

0.50

2.0

1.2

0.34

0.30

g/l

—

Congenital malformations of the urinary system, including avohilmo

1.42

0.50

1.2

0.31

0.29

g/l

—

Complications of labour and delivery

161

817

1.09

0.50

1.2

0.29

0.30

g/l

1.58

127

651

Major anomalies of jaw size

1.47

0.50

1.3

1.2

0.30

0.29

g/l

—

Other benign neoplasms of connective and other soft tissue

153

1.31

0.50

1.3

1.2

0.35

0.29

g/l

1.43

126

Supervision of normal pregnancy

326

1.16

0.50

1.2

0.28

0.30

g/l

1.97

267

Heart failure and bmi 25plus

301

1.17

0.50

1.2

1.3

0.36

0.30

g/l

4.19

245

Other and unspecified nonorganic psychotic disorders

352

1.19

0.50

1.1

1.2

0.31

0.29

g/l

1.24

286

Other disorders of cornea

136

1.32

0.49

1.2

0.30

g/l

0.25

110

Malignant neoplasm of digestive organs

414

0.85

0.49

1.4

1.2

0.32

0.31

g/l

0.15

337

Malignant neoplasm of bladder, including Hilmo

100

1.38

0.48

1.4

1.2

0.28

0.31

g/l

—

Venous complications and haemorrhoids in pregnancy

1.53

0.48

1.3

1.2

0.28

0.29

g/l

—

Ovarian dysfunction

190

1.26

0.48

1.3

0.32

0.28

g/l

1.00

154

Puerperal sepsis

208

1.25

0.47

1.6

1.2

0.30

0.31

g/l

0.24

170

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

208

1.25

0.47

1.5

1.2

0.32

0.30

g/l

0.63

166

Malignant neoplasm of breast, ER-negative, including Hilmo

322

0.81

0.47

1.2

0.30

0.31

g/l

0.54

266

Degenerative diseases of the nervous system

264

0.82

0.47

1.0

1.3

0.33

0.32

g/l

0.27

209

In situ neoplasms

663

1.13

0.47

1.2

0.32

0.30

g/l

0.85

534

Congenital deformities of feet

1.46

0.47

1.1

0.29

g/l

—

Acne, including avohilmo

446

1.14

0.45

1.4

1.2

0.28

0.29

g/l

0.31

367

malignant neoplasm of male genital organs

200

0.81

0.45

1.2

1.3

0.33

0.31

g/l

0.78

164

Malignant neoplasm

173

1094

0.93

0.44

1.3

1.2

0.30

0.31

g/l

0.15

139

875

Myocardial infarction, with ST-elevation

157

1.27

0.43

1.5

1.2

0.32

0.31

g/l

0.50

120

Oral leukoplakia, including avohilmo

1.62

0.43

2.2

1.2

0.26

0.28

g/l

—

Lesion of sciatic nerve

1.61

0.43

1.4

1.3

0.28

0.29

g/l

—

Malignant neoplasm of skin, including Hilmo

592

0.89

0.43

1.2

0.31

g/l

0.02

484

malignant neoplasm of male genital organs, including Hilmo

204

0.82

0.41

1.2

0.33

0.31

g/l

1.03

167

Infectious mononucleosis, including avohilmo

176

1.25

0.41

1.1

1.2

0.24

0.28

g/l

1.52

141

Infectious mononucleosis

176

1.25

0.41

1.1

1.2

0.24

0.28

g/l

1.52

141

Adjustment and management of implanted device

185

1.24

0.41

1.3

0.35

0.30

g/l

2.26

146

Ulcerative colitis (strict definition, require KELA)

295

1.19

0.41

1.1

1.2

0.30

0.29

g/l

0.28

235

Mumps

1.52

0.41

1.4

1.2

0.35

0.28

g/l

—

Focal epilepsy, strict definition

295

1.19

0.41

1.4

1.2

0.31

0.30

g/l

0.30

240

Congenital stenosis of pulmonary valve

0.00

0.41

0.0

1.3

—

0.31

—

Brain glioblastoma

0.00

0.41

0.0

1.1

—

0.28

—

Distal bite

1.37

0.40

1.2

0.28

0.29

g/l

0.12

Malignant neoplasm

174

1095

0.93

0.40

1.3

1.2

0.30

0.31

g/l

0.17

139

876

Mumps, including avohilmo

1.47

0.40

1.4

1.2

0.35

0.28

g/l

—

Injury of muscle and tendon at wrist and hand level

186

1.24

0.40

1.3

1.2

0.30

g/l

0.06

149

Localized scleroderma [morphea]

0.00

0.40

0.0

1.2

—

0.27

—

Burn and corrosion of hip and lower limb, except ankle and foot

1.43

0.39

1.2

1.1

0.28

g/l

—

Other diseases of spinal cord

1.43

0.39

1.0

1.2

0.36

0.27

g/l

—

Acute appendicitis, with complications

297

1.18

0.39

1.3

1.2

0.30

g/l

0.01

243

Other strabismus

427

1.14

0.38

1.2

1.3

0.34

0.29

g/l

1.65

349

Medicines for HER+ breast cancer

602

1.11

0.37

1.3

1.2

0.32

0.31

g/l

0.71

491

Malignant neoplasm of digestive organs, including Hilmo

449

0.88

0.37

1.4

1.2

0.32

0.31

g/l

0.28

366

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

290

1.17

0.36

1.1

1.2

0.31

0.29

g/l

0.42

231

Inguinal hernia

100

607

1.09

0.36

1.2

0.31

0.30

g/l

0.34

489

Dislocation, sprain and strain of joint and ligaments of hip

1.43

0.35

1.0

1.2

0.34

0.28

g/l

—

Ectopic pregnancy

347

1.15

0.35

1.2

0.31

0.30

g/l

0.18

289

Open wound of head

101

870

1.09

0.35

1.2

0.33

0.30

g/l

2.76

701

All dysplastic lesions of the cervix uteri, vagina or vulva

755

1.10

0.35

1.2

0.29

0.30

g/l

0.54

598

Primary ovarian failure

1.34

0.34

2.0

1.2

0.35

0.29

g/l

—

Multiple myeloma, including Hilmo

1.33

0.33

1.3

1.1

0.32

0.30

g/l

—

Mixed conductive and sensorineural hearing loss

145

1.24

0.33

1.6

1.3

0.31

0.30

g/l

0.18

121

Later onset COPD

205

1.18

0.33

1.2

1.3

0.34

0.31

g/l

1.01

161

Fall on and from ladder

0.67

0.33

1.0

1.2

0.30

g/l

—

Diabetic retinopathy

363

1.11

0.32

1.3

1.2

0.34

0.32

g/l

0.92

294

Solid cancers

172

1071

0.94

0.32

1.3

1.2

0.31

g/l

0.00

137

857

Lesion of lateral popliteal nerve

1.35

0.31

1.0

1.2

0.35

0.29

g/l

—

Solid cancers, including Hilmo

179

1104

0.94

0.30

1.3

1.2

0.30

g/l

0.13

141

884

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

184

1.20

0.30

1.5

1.2

0.32

0.31

g/l

0.18

148

Fracture of forearm

117

979

1.07

0.30

1.2

0.31

0.30

g/l

0.17

795

Other appendicitis

129

1.24

0.30

1.2

0.32

0.30

g/l

—

109

Laparoscopic right hemicolectomy

1.27

0.30

1.0

1.3

0.32

0.29

g/l

—

Tuberculosis, IBD comorbidity

1.27

0.30

1.0

1.2

0.32

0.30

g/l

—

Poor fetal growth

346

0.87

0.29

1.2

0.33

0.29

g/l

1.35

286

Other complications of labour and delivery, not elsewhere classified

316

0.87

0.29

1.1

1.2

0.28

0.29

g/l

0.51

253

Schizophrenia, schizotypal and delusional disorders

564

1.10

0.28

1.1

1.3

0.33

0.30

g/l

2.03

452

Delivery

469

0.92

0.28

1.2

0.29

0.31

g/l

0.96

375

Basal cell carcinoma

457

0.91

0.28

1.3

1.2

0.31

g/l

0.15

375

Scissor bite

1.28

0.28

1.1

1.2

0.30

0.27

g/l

—

Gonarthrosis, primary, with knee surgery

657

1.08

0.27

1.4

1.3

0.32

0.31

g/l

1.03

539

Glaucoma

709

1.08

0.27

1.2

0.31

g/l

0.29

573

Benign mammary dysplasia

215

1.16

0.26

1.1

1.2

0.31

g/l

0.12

173

Meningitis

1.19

0.26

1.4

1.2

0.31

0.29

g/l

—

Obstructed labour due to maternal pelvic abnormality

272

1.14

0.26

1.3

1.2

0.32

0.31

g/l

0.41

230

Presbyopia

132

1.21

0.25

1.3

0.29

g/l

—

109

All dysplastic lesions of the cervix uteri

684

1.08

0.24

1.2

0.29

g/l

0.40

548

Aortic valve malfunction, age under 60 years

137

0.80

0.24

1.5

1.2

0.30

g/l

—

116

Ulcerative colitis (strict definition, all Crohn cases excluded)

246

1.14

0.23

1.0

1.2

0.29

0.30

g/l

0.09

195

Burns and corrosions confined to eye and internal organs

1.32

0.23

1.2

0.34

0.28

g/l

—

Schizophrenia or delusion

562

1.09

0.23

1.1

1.3

0.32

0.30

g/l

1.79

449

Malignant neoplasm, including Hilmo

184

1121

0.96

0.23

1.3

1.2

0.30

g/l

0.27

145

899

Chondromalacia

1.28

0.23

1.2

0.31

0.29

g/l

—

Alcohol-induced acute pancreatitis

1.28

0.23

1.2

0.29

g/l

—

Other pulmonary heart/vessel disease

1.28

0.23

1.2

0.32

0.30

g/l

—

Malignant neoplasm, without specification of site, including Hilmo

1.25

0.22

1.2

1.1

0.36

0.30

g/l

—

Malignant neoplasm of pancreas, including Hilmo

1.27

0.22

1.4

1.2

0.36

0.31

g/l

—

Cardiovascular disorders originating in the perinatal period

0.00

0.21

0.0

1.3

—

0.31

—

Maxillary hypoplasia

0.00

0.21

0.0

1.1

—

0.30

—

Seronegative juvenile rheumatoid arthritis

1.19

0.21

1.0

1.1

0.30

g/l

—

Unspecified transport accident

0.00

0.21

0.0

1.2

—

0.30

—

Pectus excavatum

0.00

0.21

0.0

1.0

—

0.30

—

Acne conglobata

0.00

0.21

0.0

1.0

—

0.29

—

Exposure to excessive natural cold

0.00

0.21

0.0

1.2

—

0.29

—

Pectus excavatum, including avohilmo

0.00

0.21

0.0

1.1

—

0.29

—

Multiple delivery

188

0.85

0.21

1.1

1.3

0.31

g/l

0.11

149

Bacterial meningitis

1.16

0.21

1.6

1.1

0.33

0.29

g/l

—

Cleft lip and palate

0.00

0.21

0.0

1.1

—

0.30

—

Osteochondrosis of ankle, juvenile

0.00

0.20

0.0

1.0

—

0.30

—

Benign lipomatous neoplasm

470

1.09

0.20

1.4

1.2

0.31

g/l

0.01

379

Secondary and unspecified malignant neoplasm of lymph nodes

1.21

0.19

1.8

1.2

0.33

0.31

g/l

0.30

Abnormal findings on antenatal screening of mother

231

1.13

0.19

1.3

1.2

0.27

0.29

g/l

0.44

189

Postpartum haemorrhage due to anatomy

260

1.12

0.19

1.2

0.27

0.29

g/l

0.70

211

Cardiac arrest

1.21

0.18

1.4

0.28

0.30

g/l

—

Carcinoma in situ of cervix uteri

242

1.12

0.18

1.1

1.2

0.30

0.29

g/l

0.27

198

Secondary uncertain malignant neoplasm

147

1.16

0.18

1.6

1.2

0.32

0.31

g/l

0.19

117

Organic, including symptomatic, mental disorders

466

0.94

0.18

1.2

1.3

0.32

0.31

g/l

0.12

376

LSIL lesion of the cervix uteri

279

0.90

0.17

1.2

0.29

g/l

0.20

229

Tuberculosis, wide

1.15

0.17

1.0

1.2

0.32

0.29

g/l

—

Tuberculosis, wide, including avohilmo

1.15

0.17

1.0

1.2

0.32

0.29

g/l

—

Lymphoid leukaemia

1.13

0.17

2.9

1.2

0.23

0.30

g/l

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

469

0.94

0.16

1.3

1.2

0.31

g/l

0.09

384

Malignant neoplasm, wide definition

186

1119

0.97

0.16

1.3

1.2

0.30

g/l

0.36

147

897

Molar incisor enamel hypoplasia

1.16

0.15

1.3

1.1

0.31

0.29

g/l

—

Congenital malformations of heart and great arteries

219

1.11

0.15

1.1

1.2

0.28

0.29

g/l

0.28

182

Primary coxarthrosis, bilateral

332

1.08

0.15

1.1

1.3

0.32

0.31

g/l

0.11

276

L02BA Anti-estrogens

284

1.09

0.15

1.2

0.32

0.31

g/l

0.68

230

Complications of internal orthopaedic prosthetic devices, implants and grafts

247

1.09

0.13

1.2

1.3

0.31

g/l

0.15

200

Kela-code for severe mental illness

666

1.05

0.13

1.1

1.3

0.33

0.30

g/l

2.86

537

Coxarthrosis, primary, with hip surgery

577

0.95

0.13

1.2

1.3

0.31

g/l

0.05

476

Coronary artery bypass grafting

191

1.09

0.12

1.2

1.4

0.31

g/l

0.12

151

Heart failure and coronary heart disease

344

1.06

0.12

1.3

0.35

0.31

g/l

2.56

278

Conductive and sensorineural hearing loss

148

953

1.03

0.11

1.3

1.2

0.31

g/l

0.08

112

784

Leiomyoma of uterus

139

804

0.97

0.11

1.3

1.2

0.31

0.30

g/l

0.53

114

633

Cardiodefibrillation

412

0.94

0.10

1.5

1.3

0.30

0.31

g/l

0.50

331

Open wound of abdomen, lower back and pelvis

1.14

0.10

1.0

1.2

0.28

0.29

g/l

—

Mixed disorders of conduct and emotions

1.11

0.10

1.2

0.30

0.29

g/l

—

Primary open-angle glaucoma, strict

280

1.07

0.09

1.3

1.2

0.35

0.32

g/l

0.99

222

Benign leiomyoma with endometriosis

238

0.92

0.09

1.3

1.2

0.30

0.31

g/l

0.12

193

Malignant neoplasm of mesothelium and soft tissue

1.06

0.09

1.4

1.1

0.32

0.30

g/l

—

Other assisted single delivery

1.03

0.08

1.0

1.3

0.30

g/l

—

Coxarthrosis, primary

736

0.97

0.08

1.2

1.3

0.31

g/l

0.29

609

Postpartum haemorrhage

566

1.03

0.08

1.2

0.29

0.30

g/l

0.73

445

Crowding of teeth, including avohilmo

170

1.07

0.07

1.5

1.2

0.29

0.28

g/l

0.19

138

Maternal care for known or suspected fetal abnormality and damage

388

0.96

0.07

1.2

0.28

0.29

g/l

0.51

322

Sensorineural hearing loss

128

871

0.98

0.07

1.3

1.2

0.30

0.31

g/l

0.49

719

Long labour

525

1.03

0.07

1.1

1.2

0.29

0.30

g/l

0.21

414

Other disorders of optic [2nd] nerve and visual pathways

0.88

0.06

1.5

1.2

0.29

g/l

—

LSIL lesion of the cervix uteri, vagina or vulva

356

0.95

0.06

1.1

1.2

0.30

0.29

g/l

0.13

291

Valvular heart disease excluding rheumatic fever

485

0.97

0.06

1.3

1.2

0.31

0.30

g/l

0.25

394

Primary open-angle glaucoma

332

1.04

0.06

1.3

0.34

0.31

g/l

1.09

262

Sequelae of cerebrovascular disease

354

1.04

0.05

1.3

0.33

0.31

g/l

1.13

285

Non-rheumatic valve diseases

483

0.97

0.05

1.3

1.2

0.31

g/l

0.24

392

Delivery, wide proxy

383

1.02

0.05

1.2

0.29

0.31

g/l

0.93

307

Antepartum haemorrhage, not elsewhere classified

231

0.95

0.04

1.2

0.30

0.29

g/l

0.36

187

Postpartum hemorraghe, parous women as controls

581

1.02

0.04

1.2

0.29

0.30

g/l

0.41

461

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

496

0.98

0.04

1.3

1.2

0.31

g/l

0.10

404

Basal cell carcinoma, including Hilmo

474

1.01

0.02

1.3

1.2

0.31

g/l

0.13

386

Calcific aortic valvular stenosis

277

0.97

0.01

1.1

1.3

0.35

0.31

g/l

1.52

218

Calcific aortic valvular stenosis, operated

277

0.97

0.01

1.1

1.3

0.35

0.31

g/l

1.52

218

Glucosamine medication

469

0.99

0.01

1.3

1.2

0.30

0.32

g/l

0.86

378

Postpartum hemorraghe, all women as controls

699

0.99

0.01

1.2

0.29

0.30

g/l

0.37

563

Malignant melanoma, including Hilmo

226

0.97

0.00

1.1

1.2

0.33

0.31

g/l

0.52

184

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

314

1.02

0.00

1.1

1.2

0.35

0.31

g/l

1.84

256

malignant neoplasm of female genital organs

206

1.00

0.00

1.4

1.2

0.33

0.31

g/l

0.23

168

Sulfonylureas

250

1.02

0.00

1.1

1.3

0.35

0.31

g/l

2.05

198

Calcific aortic valvular stenosis, including rheumatic fever

274

0.98

0.00

1.1

1.3

0.35

0.31

g/l

1.60

216

Malignant neoplasm of breast, ER-positive, including Hilmo

477

1.00

0.00

1.3

1.2

0.31

g/l

0.19

390

Antenatal screening

336

1.00

0.00

1.2

0.28

0.30

g/l

2.43

273

Left ventricular outflow tract obstruction (LVOTO), broad definition

145

0.97

0.00

1.4

1.2

0.30

g/l

—

124

Calcific aortic valvular stenosis, diagnosis (helper)

274

0.98

0.00

1.1

1.3

0.35

0.31

g/l

1.60

216

Operations 2 for CAVS

274

0.98

0.00

1.1

1.3

0.35

0.31

g/l

1.60

216

malignant neoplasm of female genital organs, including Hilmo

251

0.99

0.00

1.4

1.2

0.32

0.31

g/l

0.32

207

Malignant neoplasm of breast, HER-positive

477

1.00

0.00

1.3

1.2

0.31

g/l

0.19

390

Failed induction of labour

163

0.98

0.00

1.3

1.2

0.27

0.29

g/l

0.59

131

Unspecified protein-energy malnutrition

0.00

0.0

1.2

—

0.34

—

Birth injury to skeleton

0.00

0.0

1.0

—

0.35

—

Klinefelter syndrome, karyotype 47 XXY

0.00

0.0

1.0

—

0.26

—

Osteogenesis imperfecta

0.00

0.0

1.0

—

0.36

—

Imperforate hymen

0.00

0.0

1.0

—

0.31

—

Telogen effluvium

0.00

0.0

1.1

—

0.29

—

Impaction of intestines

0.00

0.0

1.1

—

0.27

—

Frostbite with tissue necrosis

0.00

0.0

1.0

—

0.31

—

Other superficial injuries of ankle and foot

0.00

0.0

1.1

—

0.29

—

Rheumatoid lung disease

0.00

0.0

1.0

—

0.33

—

Brain astrocytoma, helper endpoint

0.00

0.0

1.1

—

0.28

—

Contact with other and unspecified heat and hot substances

0.00

0.0

1.0

—

0.28

—

Acute disseminated encephalitis/encephalomyelitis

0.00

0.0

1.2

—

0.27

—

Congenital heart conduction disorder

0.00

0.0

1.0

—

0.30

—

Congenital ptosis, including avohilmo

0.00

0.0

1.0

—

0.29

—

Rheumatic fever with heart involvement

0.00

0.0

1.0

—

0.35

—

ILD and respiratory illness in diseases classified elsewhere

0.00

0.0

1.0

—

0.31

—

Atrioventricular septal defect

0.00

0.0

1.2

—

0.29

—

Benign neoplasm: Eye, unspecified

0.00

0.0

1.1

—

0.30

—

Cervical root disorders

0.00

0.0

1.4

—

0.27

—

Apocrine sweat disorders, other sweat gland disorders

0.00

0.0

1.3

—

0.32

—

0.00

0.0

1.0

—

0.33

—

Sequelae of burns, corrosions and frostbite

0.00

0.0

1.1

—

0.29

—

Cholesteatoma of middle ear

1.00

-0.00

1.2

0.33

0.28

g/l

—

Hereditary spherocytosis

0.00

-0.00

0.0

1.0

—

0.33

—

Chronic respiratory disease originating in the perinatal period

0.00

-0.00

0.0

1.0

—

0.32

—

Acromegaly and pituitary gigantism

0.00

-0.00

0.0

1.3

—

0.30

—

Unspecified severe protein-energy malnutrition

0.00

-0.00

0.0

1.0

—

0.37

—

Systemic disorders of connective tissue in diseases classified elsewhere (FG)

0.00

-0.00

0.0

1.2

—

0.29

—

Haemolytic disease of fetus and newborn

0.00

-0.00

0.0

1.6

—

0.27

—

Retrobulbar neuritis in diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

0.34

—

Localized adiposity

0.00

-0.00

0.0

1.3

—

0.29

—

Arthropathy in hypersensitivity reactions classified elsewhere

0.00

-0.00

0.0

1.0

—

0.30

—

Undefined dementia

0.96

-0.00

1.1

1.2

0.35

0.30

g/l

—

Acquired pure red cell aplasia [erythroblastopenia]

0.00

-0.00

0.0

1.2

—

0.29

—

Other benign neoplasms of uterus

0.91

-0.00

1.0

1.2

0.35

0.30

g/l

—

Benign neoplasm: Rectum/anal canal icd-9

0.00

-0.00

0.0

1.0

—

0.34

—

Benign neoplasm: Carotid body

0.00

-0.00

0.0

1.0

—

0.33

—

Familial erythrocytosis

0.00

-0.00

0.0

1.2

—

0.30

—

Café au lait spots

0.00

-0.00

0.0

1.0

—

0.31

—

Acrodermatitis continua

0.00

-0.00

0.0

1.0

—

0.31

—

Glaucoma secondary to drugs

0.00

-0.00

0.0

1.0

—

0.31

—

Thyrotoxicosis factitia

0.00

-0.00

0.0

1.2

—

0.30

—

Tuberous sclerosis 1

0.00

-0.00

0.0

1.2

—

0.28

—

Chronic thyroiditis

0.00

-0.00

0.0

1.0

—

0.30

—

Systemic disorders of connective tissue in diseases classified elsewhere

0.00

-0.00

0.0

1.1

—

0.28

—

Congenital malformations of oesophagus

0.00

-0.00

0.0

1.1

—

0.31

—

Other conditions of integument specific to fetus and newborn

0.00

-0.00

0.0

1.0

—

0.26

—

Benign neoplasm: Urinary organ, other/unspecified

0.00

-0.00

0.0

1.0

—

0.31

—

Benign neoplasm: Lower jaw bone

0.00

-0.00

0.0

1.2

—

0.33

—

Fetus and newborn affected by other complications of labour and delivery

0.00

-0.00

0.0

1.0

—

0.32

—

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

0.00

-0.00

0.0

1.2

—

0.33

—

Idiopathic peripheral autonomic neuropathy

0.00

-0.00

0.0

1.1

—

0.31

—

Myotonic dystrophy (Steinert)

0.00

-0.00

0.0

1.2

—

0.33

—

Other endophthalmitis

0.00

-0.00

0.0

1.2

—

0.33

—

Neonatal aspiration syndromes

0.00

-0.00

0.0

1.0

—

0.27

—

Carcinoma in situ of middle ear and respiratory system

0.00

-0.00

0.0

1.2

—

0.31

—

Hookworm diseases

0.00

-0.00

0.0

1.0

—

0.31

—

Hypoplasia of dental enamel , including avohilmo

0.93

-0.00

1.0

1.2

0.33

0.29

g/l

—

Tympanosclerosis

0.00

-0.00

0.0

1.0

—

0.30

—

Mental and behavioural disorders due to use of volatile solvents

0.00

-0.00

0.0

1.0

—

0.29

—

Mantle cell lymphoma

0.00

-0.00

0.0

1.1

—

0.34

—

Disorders of muscle tone of newborn

0.00

-0.00

0.0

1.0

—

0.27

—

Nosocomial condition (hospital)

0.00

-0.00

0.0

1.1

—

0.30

—

Malignant neoplasm of peripheral nerves and autonomic nervous system, including Hilmo

0.00

-0.00

0.0

1.2

—

0.33

—

Exposure to ignition or melting of other clothing and apparel

0.00

-0.00

0.0

1.0

—

0.32

—

Carcinoma in situ of skin of other and unspecified parts of face

0.96

-0.00

1.6

1.2

0.34

0.31

g/l

—

Brain astrocytoma

0.00

-0.00

0.0

1.0

—

0.30

—

Malignant neoplasm of other endocrine glands and related structures, including Hilmo

0.00

-0.00

0.0

1.0

—

0.34

—

Carcinoma in situ of oral cavity, oesophagus and stomach

0.00

-0.00

0.0

1.2

—

0.32

—

Benign neoplasm: Mediastinum

0.00

-0.00

0.0

1.1

—

0.30

—

Respiratory tuberculosis, clinically confirmed

0.00

-0.00

0.0

1.3

—

0.30

—

Brain astrocytoma, including Hilmo

0.00

-0.00

0.0

1.0

—

0.30

—

Osteitis due to dental implant

0.00

-0.00

0.0

1.3

—

0.33

—

ILD medications: nintedanib

0.00

-0.00

0.0

1.4

—

0.26

—

Metabolic disorder, other/unspecified

0.00

-0.00

0.0

1.1

—

0.32

—

Disorder of mineral metabolism, other/unspecified

0.00

-0.00

0.0

1.0

—

0.32

—

Rare circulating lymphoid malignancy

0.00

-0.00

0.0

1.1

—

0.27

—

Malignant neoplasm of bone and articular cartilage of limbs

0.00

-0.00

0.0

1.1

—

0.34

—

Frostbite involving multiple body regions and unspecified frostbite

0.00

-0.00

0.0

1.0

—

0.30

—

Deaf mutism, not elsewhere classified

0.00

-0.00

0.0

1.2

—

0.32

—

Other hypertrichosis

0.00

-0.00

0.0

1.1

—

0.27

—

Epidural haemorrhage

0.00

-0.00

0.0

1.3

—

0.29

—

Glaucoma, exfoliation

0.91

-0.00

1.4

1.2

0.36

0.31

g/l

—

Cytomegaloviral hepatitis

0.00

-0.00

0.0

1.2

—

0.30

—

Burn and corrosion of other internal organs

0.00

-0.00

0.0

1.0

—

0.29

—

Other operation for atrial fibrillation

0.00

-0.00

0.0

1.2

—

0.31

—

Sequelae of poisoning by drugs, medicaments and biological substances

0.00

-0.00

0.0

1.2

—

0.29

—

Polyglandular dysfunction

0.00

-0.00

0.0

1.0

—

0.31

—

Unicornuate uterus

0.00

-0.00

0.0

1.2

—

0.28

—

Radiodermatitis

0.00

-0.00

0.0

1.2

—

0.33

—

Burn and corrosion of wrist and hand

0.98

-0.00

1.7

1.2

0.25

0.29

g/l

—

Congenital malformation syndromes predominantly affecting facial appearance

0.00

-0.00

0.0

1.0

—

0.28

—

Other helminthiases, including avohilmo

0.00

-0.00

0.0

1.2

—

0.26

—

Labyrinthitis

0.00

-0.00

0.0

1.0

—

0.32

—

Reduction defects of upper limb

0.00

-0.00

0.0

1.0

—

0.37

—

Turner's syndrome

0.00

-0.00

0.0

1.1

—

0.28

—

Other salmonella infections, including avohilmo

0.96

-0.00

1.0

1.1

0.31

0.29

g/l

—

Complications of anaesthesia during labour and delivery

0.00

-0.00

0.0

1.1

—

0.31

—

Postprocedural disorders of ear and mastoid process, not elsewhere classified

0.00

-0.00

0.0

1.1

—

0.32

—

Valgus deformity, not elsewhere classified

0.00

-0.00

0.0

1.3

—

0.26

—

Use of riluzole

0.00

-0.00

0.0

1.4

—

0.31

—

Congenital mitral valve regurgitation

0.00

-0.00

0.0

1.0

—

0.37

—

Fusion of the labia, including avohilmo

0.00

-0.00

0.0

1.0

—

0.28

—

Reduction defects of upper limb, including avohilmo

0.00

-0.00

0.0

1.1

—

0.35

—

Congenital ptosis

0.00

-0.00

0.0

1.0

—

0.29

—

Congenital absence, atresia and stenosis of small intestine

0.00

-0.00

0.0

1.0

—

0.36

—

Other specified transport accidents

0.00

-0.00

0.0

1.0

—

0.30

—

Syndactyly, including avohilmo

0.00

-0.00

0.0

1.0

—

0.33

—

Unspecified dementia

0.97

-0.00

1.1

1.2

0.35

0.31

g/l

—

Intercostal neuropathy

0.00

-0.00

0.0

1.3

—

0.30

—

Immunodeficiency associated with other major defects

0.00

-0.00

0.0

1.0

—

0.30

—

Fluid overload

0.00

-0.00

0.0

1.4

—

0.28

—

Other disorders of carbohydrate metabolism

0.00

-0.00

0.0

1.0

—

0.29

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS